<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>BioC-API</source><date>20250617</date><key>collection.key</key><document><id>PMC11568600</id><infon key="license">CC BY-NC-ND</infon><passage><infon key="article-id_doi">10.1186/s12864-024-11034-2</infon><infon key="article-id_pmc">PMC11568600</infon><infon key="article-id_pmid">39550580</infon><infon key="article-id_publisher-id">11034</infon><infon key="elocation-id">1095</infon><infon key="kwd">Bisphenol S Diet Metabolic status Adiposity Granulosa cells Protein Proteomic Ewes Ovary</infon><infon key="license">Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.</infon><infon key="name_0">surname:Lebachelier de la Riviere;given-names:Marie-Emilie</infon><infon key="name_1">surname:Teteau;given-names:Ophelie</infon><infon key="name_10">surname:Saint-Dizier;given-names:Marie</infon><infon key="name_11">surname:Binet;given-names:Aurelien</infon><infon key="name_12">surname:Elis;given-names:Sebastien</infon><infon key="name_2">surname:Mahe;given-names:Coline</infon><infon key="name_3">surname:Lasserre;given-names:Olivier</infon><infon key="name_4">surname:Desmarchais;given-names:Alice</infon><infon key="name_5">surname:Uzbekova;given-names:Svetlana</infon><infon key="name_6">surname:Papillier;given-names:Pascal</infon><infon key="name_7">surname:Tomas;given-names:Daniel</infon><infon key="name_8">surname:Labas;given-names:Valerie</infon><infon key="name_9">surname:Maillard;given-names:Virginie</infon><infon key="section_type">TITLE</infon><infon key="title">Keywords</infon><infon key="type">front</infon><infon key="volume">25</infon><infon key="year">2024</infon><offset>0</offset><text>Metabolic status is a key factor influencing proteomic changes in ewe granulosa cells induced by chronic BPS exposure</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>118</offset><text>Background</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>129</offset><text>Bisphenol S (BPS) is the main substitute for bisphenol A (BPA), a well-known plasticiser and endocrine disruptor. BPS disrupts ovarian function in several species. Moreover, a few studies have reported that the effects of BPS might be modulated by the metabolic status, and none have characterised the granulosa cell (GC) proteome after chronic BPS exposure.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>488</offset><text>Objectives</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>499</offset><text>This study aimed to decipher the mechanisms of action of chronic BPS exposure on the proteome of ewe GCs while considering the interaction between a deliberate contrasted metabolism and reproductive function.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>708</offset><text>Methods</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>716</offset><text>Forty ewes were split into two groups with contrasted diets: restricted (R, n = 20) and well-fed (WF, n = 20). The R and WF ewes were subdivided according to the dose of BPS administered through the diet (0-50 microg/kg/day), forming four groups: R0, R50, WF0 and WF50. After 3-month BPS daily exposure, GCs were recovered during the pre-ovulatory stage and proteins were analysed by nano-liquid chromatography coupled with tandem mass spectrometry.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1174</offset><text>Results</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1182</offset><text>Chronic exposure to BPS affected the GC proteome differently according to the ewe metabolic status. Fifty-nine out of 958 quantified proteins were differentially abundant between groups and are mainly involved in carbohydrate and lipid pathways. Unsupervised hierarchical clustering of differentially abundant proteins (DAPs) identified four clusters of 34, 6, 5 and 14 proteins according to the BPS exposure and diet interaction. Pairwise comparisons between groups also revealed a strong effect of BPS exposure and diet interaction. Functional analysis of DAPs highlighted that BPS upregulated beta-glucuronidase (GUSB; p = 0.002), a protein especially able to deconjugate bisphenol glucuronides (BP-g). Moreover, among unexposed ewes, GUSB was detected only in well-fed ewes.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1963</offset><text>Discussion</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1974</offset><text>Conjugation of glucuronides inhibits the oestrogenic activity of bisphenols. Upregulation of GUSB in ewes dosed with BPS would prolong the oestrogenic effects of BPS by deconjugating BPS-g into free BPS. In addition, literature has reported an up-regulation of GUSB in people suffering from obesity. Therefore, people suffering from obesity could be subjected to prolonged and aggravated exposure to BPS. These data highlighted the deleterious effects of BPS and its interaction with metabolic status.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>2476</offset><text>Supplementary Information</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>2502</offset><text>The online version contains supplementary material available at 10.1186/s12864-024-11034-2.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2594</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2607</offset><text>Bisphenol A (BPA), one of the most widely produced plasticisers throughout the world, is recognised as an endocrine disruptor. Several studies have highlighted the harmful effects of BPA on human health, particularly on female reproduction through alterations in steroidogenesis (oestradiol, progesterone, etc.), ovarian diseases (polycystic ovary syndrome), unfavourable pregnancy outcomes and reduced fertility. The main route of exposure is oral ingestion, due to the transfer of bisphenol molecules from food packaging to its contents, given that BPA is widely used in the food industry. The most important detoxification reaction for bisphenols is the conjugation reaction with glucuronic acid, which promotes urine excretion of these molecules. Given its status as an endocrine disruptor, BPA has been banned in the food industry in Canada, Belgium and France and replaced by its structural analogues, in particular bisphenol S (BPS). BPS has been detected in human fluids, such as urine, follicular fluid and serum. BPS is known as an oestrogen mimetic that can modulate steroidogenesis by binding to oestrogen receptors; moreover, it has been reported to exhibit an androgenic effect, although these results are controversial. Granulosa cells (GCs) are somatic cells surrounding the oocyte in the ovarian follicle; they are involved in follicle growth and steroidogenesis, enabling oocyte maturation. There is also a dialogue between these cells and the oocyte, which is essential for ovulation. Several in vitro studies in different mammalian species have demonstrated BPS-induced disruption of oestradiol and/or progesterone secretion in GCs, although these effects varied according to the dose and duration of BPS exposure. The deleterious effects of BPS on health, in particular reproductive function and/or metabolic disorders, are sometimes even worse than those of BPA.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4492</offset><text>In female mammals, reproduction requires adaptations to energy metabolism. Indeed, an insufficient body fat mass leads to a loss of cyclicity and, conversely, overweight or obesity can lead to complications such as an increased risk of miscarriage, impaired cumulus-oocyte complex development and impaired early embryonic development. A higher body mass index (BMI) can also be associated with alterations in the follicular fluid composition, with increased follicular insulin, glucose and lactate concentrations, and obesity exerts effects on sex hormone secretion and metabolism, resulting in changes in the bioavailability of both oestrogens and androgens.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5152</offset><text>BPA has been associated with obesity in humans and promotes adipogenesis and lipid accumulation by impacting lipid and glucose metabolism via the peroxisome proliferator-activated receptor gamma (PPARgamma) receptor signalling pathway. Therefore, bisphenols are able to modulate energy metabolism, which adversely affects female reproduction and cellular functions. For example, bisphenols are able to impair steroidogenesis of cumulus cells, granulosa cells and/or theca cells in several species including bovine, rodent, ovine and human. BPS also altered ewe oocyte developmental capacity by inducing a decrease in oocyte maturation rate, in embryo cleavage rate and in blastocyst rate in ovine. Finally, the negative effect of BPS may be exacerbated by the metabolic status. Indeed, oestradiol increased in the follicular fluid of only well-fed animals while there was no effect in animals on a restricted diet. Therefore, excess in diet can contribute to impaired reproduction. Similarly, an interaction between chronic exposure to BPS and the metabolic status has been reported to affect the efficiency of in vitro embryo production negatively, whereas BPS or diet al.one had no effect in ewes receiving contrasted diets (restricted or well fed).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6404</offset><text>The aim of this study was to investigate the mechanisms of action of chronic BPS exposure, according to the metabolic status of the animal, on ewe GCs by proteomic analysis to consider the interaction between metabolism and ovarian follicular function. Forty ewes were fed contrasted diets and exposed or unexposed to oral BPS for at least 3 months. The GCs were collected at the pre-ovulatory stage of the cycle; protein was extracted, pooled and analysed by nano-liquid chromatography coupled to tandem mass spectrometry (nanoLC-MS/MS).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>6943</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>6951</offset><text>Validation of the diet model and detection of BPS and its metabolite in the follicular fluid of exposed ewes</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7060</offset><text>Ewe body weight (BW) and body condition score (BCS) differed significantly between the WF and R groups (Table 1). The mean BW and BCS of restricted ewes were lower than well-fed ewes, with a mean difference of 11 kg in BW (52.6 +- 1.2 kg vs. 63.5 +- 1.2 kg in restricted and well-fed ewes, respectively, p &lt; 0.001) and almost 1 BCS point (2.05 +- 0.07 vs. 2.88 +- 0.05 in restricted and well-fed ewes, respectively, p &lt; 0.001). Despite overfeeding (165% of their maintenance energy requirements), well-fed ewes were not overweighted (BCS = 2.88 instead of 4 for typical overweighted animals); however, the plasma glucose and non-esterified fatty acids (NEFA) concentrations were increased compared with the restricted ewes (glucose: 778 +- 50 vs. 657 +- 23 mg/L, p = 0.039; NEFA: 301 +- 54 vs. 168 +- 26 micromol/L, p = 0.035). Ewes in the R50 and WF50 groups were exposed to BPS for an average of 5.4 +- 0.1 months (range: 3.6 - 7.9 months) before sample collection. BPS and its glucurono-conjugate BPS glucuronide (BPS-g), a marker of internal BPS exposure, were detected in the plasma of all exposed ewes at the time of slaughter (i.e. 24 h on average after the last exposure; Table 1), with no difference regarding diet effect. BPS-g was detected in 3 among 20 unexposed ewes at a significantly lower level compared to BPS exposed ewes (p &lt; 0.001).</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>8483</offset><text>Zootechnical parameters of ewes chronically exposed or not to BPS</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot;/&gt;&lt;th align=&quot;left&quot; colspan=&quot;4&quot;&gt;Mean +- SEM&lt;/th&gt;&lt;th align=&quot;left&quot; colspan=&quot;3&quot;&gt;&lt;italic&gt;p&lt;/italic&gt;-value&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;R0&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;R50&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;WF0&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;WF50&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Diet effect&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;BPS effect&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Diet x BPS effect&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Body weight (kg)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;53.2 +- 2.1 &lt;sup&gt;&lt;bold&gt;a&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;51.9 +- 1.4 &lt;sup&gt;&lt;bold&gt;a&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;64.0 +- 1.7 &lt;sup&gt;&lt;bold&gt;b&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;62.9 +- 1.7 &lt;sup&gt;&lt;bold&gt;b&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;bold&gt;&amp;lt; 0.001&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.511&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;1.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Body condition score&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.02 +- 0.12 &lt;sup&gt;&lt;bold&gt;a&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.08 +- 0.08 &lt;sup&gt;&lt;bold&gt;a&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.78 +- 0.08 &lt;sup&gt;&lt;bold&gt;b&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.98 +- 0.06 &lt;sup&gt;&lt;bold&gt;b&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;bold&gt;&amp;lt; 0.001&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.136&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.387&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Plasma glucose (mg/L)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;638 +- 29.6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;674 +- 35.6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;731 +- 57.9&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;822 +- 81.5&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;bold&gt;0.039&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.260&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.661&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Plasma NEFA (micromol/L)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;173 +- 48.3&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;164 +- 23.8&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;326 +- 57.9&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;276 +- 93.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;bold&gt;0.035&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.611&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.761&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Plasma BPS (nM)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.29 +- 0.29 &lt;sup&gt;&lt;bold&gt;a&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.95 +- 0.8 &lt;sup&gt;&lt;bold&gt;b&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.12 +- 0.12 &lt;sup&gt;&lt;bold&gt;a&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;2.14 +- 0.36 &lt;sup&gt;&lt;bold&gt;b&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.294&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;bold&gt;&amp;lt; 0.001&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.506&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Plasma BPS-g (nM)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.03 +- 0.02 &lt;sup&gt;&lt;bold&gt;a&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;201 +- 15.7 &lt;sup&gt;&lt;bold&gt;b&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.38 +- 0.38 &lt;sup&gt;&lt;bold&gt;a&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;188 +- 11.5 &lt;sup&gt;&lt;bold&gt;b&lt;/bold&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.510&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;bold&gt;&amp;lt; 0.001&lt;/bold&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.491&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>8549</offset><text>	Mean +- SEM	p-value	 	R0	R50	WF0	WF50	Diet effect	BPS effect	Diet x BPS effect	 	Body weight (kg)	53.2 +- 2.1 a	51.9 +- 1.4 a	64.0 +- 1.7 b	62.9 +- 1.7 b	&lt; 0.001	0.511	1.000	 	Body condition score	2.02 +- 0.12 a	2.08 +- 0.08 a	2.78 +- 0.08 b	2.98 +- 0.06 b	&lt; 0.001	0.136	0.387	 	Plasma glucose (mg/L)	638 +- 29.6	674 +- 35.6	731 +- 57.9	822 +- 81.5	0.039	0.260	0.661	 	Plasma NEFA (micromol/L)	173 +- 48.3	164 +- 23.8	326 +- 57.9	276 +- 93.1	0.035	0.611	0.761	 	Plasma BPS (nM)	0.29 +- 0.29 a	2.95 +- 0.8 b	0.12 +- 0.12 a	2.14 +- 0.36 b	0.294	&lt; 0.001	0.506	 	Plasma BPS-g (nM)	0.03 +- 0.02 a	201 +- 15.7 b	0.38 +- 0.38 a	188 +- 11.5 b	0.510	&lt; 0.001	0.491	 	</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>9314</offset><text>A body condition score is graded from 1 to 5, 2 corresponding to a slim ewe and 4 corresponding to a fat ewe. Tukey post-hoc tests are indicated by letters and values with different letters are significantly different (p &lt; 0.05). Two-way ANOVA p-values are presented for the effects of diet, dietary exposure to BPS and the interaction of these effects. Bold text indicates significant differences (p &lt; 0.05)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>9731</offset><text>Proteins identified in ewe granulosa cells (GCs)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9780</offset><text>A total of 958 proteins were identified by at least two unique peptides in GCs (Supplementary Table S1). Among these proteins, 641 proteins were common to all conditions (Fig. 1). There were 2 specific proteins identified that were common to the R0 and WF0 groups, 20 specific proteins common to the R50 and WF50 groups, 17 specific proteins common to the R0 and R50 groups and 9 specific proteins common to the WF0 and WF50 groups. The most abundant proteins among the 641 common proteins are mainly circulating/blood proteins (serum albumin, fibrinogen alpha chain, fibrinogen beta chain, fibrinogen gamma chain, immunoglobulin and haemoglobin) and structural proteins (histones and heat shock protein family A member 5; Supplementary Table S1). The 958 proteins identified in GCs are involved in metabolism, the processing of genetic or environmental information and the cellular organisation system (see Fig. 2).</text></passage><passage><infon key="file">12864_2024_11034_Fig1_HTML.jpg</infon><infon key="id">Fig1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>10699</offset><text>Comparative analysis of proteins identified in ewes Granulosa Cells (GCs)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10773</offset><text>Venn diagram showing the overlap between the different conditions (diet x BPS exposure) and histogram showing the number of proteins identified in each condition. R0 - restricted diet, no BPS, R50 - restricted diet and 50 microg/kg/day BPS exposure, WF0 - well fed diet, no BPS, WF50 - well fed diet and 50 microg/kg/day BPS exposure.</text></passage><passage><infon key="file">12864_2024_11034_Fig2_HTML.jpg</infon><infon key="id">Fig2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>11113</offset><text>Proteomaps analysis of the 958 quantified proteins in ovine GCs</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11177</offset><text>Proteomaps were generated using the KEGG (Kyoto Encyclopedia of Genes and Genomes) Pathway gene classification. Functional categories and proteins are represented by polygons. The polygon areas illustrate the normalised abundance of proteins in each condition. Functions and related proteins are organised into common regions and coded using similar colours. R0 - restricted diet, no BPS, R50 - restricted diet and 50 microg/kg/day BPS exposure, WF0 - well feed diet, no BPS, WF50 - well feed diet and 50 microg/kg/day BPS exposure.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>11714</offset><text>Global analysis of DAPs in GCs from restricted or well-fed ewes exposed or not exposed to BPS</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11808</offset><text>To assess more specifically the impact of BPS exposure and of contrasting diets on protein abundance, PCA of the 59 DAPs (ANOVA and chi-square p &lt;= 0.05; Supplementary Table S2) of the 16 GCs samples was performed (Fig. 3). The PCA explained 57% of the variance of the data (Dim1 at 37.9%, light and dark blue and Dim2 at 19.2%, turquoise and green). WF0 did not correlate well in this PCA with the horizontal or vertical axis as it was close to the center of the PCA. On the contrary, R0 (dark blue) was negatively correlated to the horizontal axis while R50 (light blue) is mainly positively correlated to the vertical axis. WF50 was positively correlated to the horizontal axis and negatively correlated to the vertical axis. There was therefore a clear discrimination between these 3 groups (R0, R50 and WF50) as they do not correlate with the same axis. Therefore, the difference between unexposed ewes or ewes exposed to BPS might be greater in the restricted groups. The heatmap representation shows the differences in significant DAPs after ANOVA and chi-square test (Fig. 4). Unsupervised hierarchical clustering identified four DAP clusters (C1 - C4): C1 (green) comprises 34 proteins (including FHIT, GUSB, VAPB and TTR) that were more abundant in BPS-exposed ewes (WF50 and R50) and WF0 than in R0. C2 (orange) comprises 6 proteins (including AKR7A2, FDFT1, HSDL1 and TNPO2) that were more abundant in BPS-exposed (WF50 and R50) than unexposed ewes. C3 (blue) comprises 5 proteins (including DCD, APOA1, CLEC3B and AMBP) that were more abundant in WF50 than in the three other conditions. Finally, C4 (pink) includes 14 proteins (including TST, NCSTN, SLC27A1 and PRKCSH) that were less abundant in the WF50 group compared with the three other groups (Table 2 and Supplementary Table S2).</text></passage><passage><infon key="file">12864_2024_11034_Fig3_HTML.jpg</infon><infon key="id">Fig3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>13623</offset><text>Principal component analysis of the 59 differentially abundant proteins according to the diet and BPS exposure</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13734</offset><text>Principal component analysis of the 59 DAPs (ANOVA p &lt;= 0.05) showing a separation of the 16 GCs samples between diet (light and dark blue: restricted (R); turquoise and green: well-fed (WF)) and BPS exposure (0-50 microg/kg/day). Each point represents a biological sample with a different diet, exposed or not to BPS (see legends for corresponding colour). The square in each confidence ellipse indicates the mean of the data for a given region. The percentage on each axis (dimension) represents the total variance of data (horizontal axis, dimension 1 and vertical axis, dimension 2). Ellipses represent the 95% interval of confidence for each group.</text></passage><passage><infon key="file">12864_2024_11034_Fig4_HTML.jpg</infon><infon key="id">Fig4</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>14393</offset><text>Heatmap and hierarchical clustering of the 59 differentially abundant proteins according to the diet and BPS exposure</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14511</offset><text>Each line corresponds to a DAP (ANOVA or Chi-square p &lt;= 0.05). For a given protein, blue lines represent lower abundance, white lines represent median abundance, while red lines represent higher abundance values relative to the other conditions. Four groups of proteins were identified by unsupervised hierarchical clustering (multicoloured vertical bars on the left). Orange bars indicate groups with higher abundance in ewes exposed to BPS. Green bars indicate a group with lower abundance in R0, blue bars indicate groups with higher abundance in ewes WF50 while pink bars indicate a group with lower abundance in WF50. The proximity between proteins is illustrated by the hierarchical tree at the left side. R0 - restricted diet, no BPS, R50 - restricted diet and 50 microg/kg/day BPS exposure, WF0 - well feed diet, no BPS, WF50 - well feed diet and 50 microg/kg/day BPS exposure.</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>15407</offset><text>Examples of main differential proteins in each cluster of the heatmap</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot;&gt;Heatmap cluster&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot;&gt;Protein name&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot;&gt;
&lt;italic&gt;Gene symbol&lt;/italic&gt;
&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot;&gt;Accession number&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot;&gt;Molecular weight&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot;&gt;Test&lt;/th&gt;&lt;th align=&quot;left&quot; rowspan=&quot;2&quot;&gt;p-Value (ANOVA or Chi-square)&lt;/th&gt;&lt;th align=&quot;left&quot; colspan=&quot;4&quot;&gt;Mean quantitative value (detection rate %)&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;in R0&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;in R50&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;in WF0&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;in WF50&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;4&quot;&gt;C1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;bis(5'-adenosyl)-triphosphatase isoform X1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;FHIT&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_011954617.2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;17 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0117&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.5 (50%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5.76 (75%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.3 (100%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;beta-glucuronidase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;GUSB&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_027817734.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;74 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0019&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.88 (100%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.18 (50%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.6 (100%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;vesicle-associated membrane protein-associated protein B/C&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;VAPB&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_017913111.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;27 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;ANOVA&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.00037&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.56&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.49&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.57&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;transthyretin precursor&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;TTR&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;NP_001009800.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;16 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;ANOVA&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0028&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;8.33&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;8.55&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;8.58&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9.17&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;4&quot;&gt;C2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;aflatoxin B1 aldehyde reductase member 2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;AKR7A2&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_027821430.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;41 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0070&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.76 (75%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.03 (100%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.21 (100%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;inactive hydroxysteroid dehydrogenase-like protein 1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;HSDL1&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;NP_001092341.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;37 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.00270&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.17 (25%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.21 (100%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.76 (75%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;squalene synthase isoform X2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;FDFT1&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_004004500.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;48 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.012&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.56 (75%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.63 (100%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.59 (50%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;transportin-2 isoform X4&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;TNPO2&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_027825368.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;103 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.003&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.32 (25%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.44 (75%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.82 (100%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;4&quot;&gt;C3&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;dermcidin isoform 1 preproprotein&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;DCD&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;NP_444513.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;11 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.046&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5.47 (50%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5.94 (75%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.41 (75%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;apolipoprotein A-I&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;APOA1&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_011950887.2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;30 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;ANOVA&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0019&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9.17&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9.14&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9.33&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;9.87&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;tetranectin precursor&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;CLEC3B&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;NP_001039677.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;22 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;ANOVA&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0,022&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.07&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.13&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.47&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;protein AMBP isoform X2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;AMBP&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_005684398.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;39 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;ANOVA&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0,033&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.97&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.07&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.14&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.53&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;4&quot;&gt;C4&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;thiosulfate sulfurtransferase&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;TST&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_014950344.2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;33 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0027&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.99 (75%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.91 (100%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;5.87 (25%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;nicastrin isoform X2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;NCSTN&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_012039753.2&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;67 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Chi-square&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.028&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.58 (50%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.8 (75%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.68 (75%)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;N.D. (0%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;long-chain fatty acid transport protein 1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;SLC27A1&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_027825247.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;71 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;ANOVA&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.0066&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.6&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.16&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.59&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;6.52&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;glucosidase 2 subunit beta&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;
&lt;italic&gt;PRKCSH&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;XP_027825495.1&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;60 kDa&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;ANOVA&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;0.023&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.22&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.94&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.91&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;7.53&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>15477</offset><text>Heatmap cluster	Protein name	Gene symbol	Accession number	Molecular weight	Test	p-Value (ANOVA or Chi-square)	Mean quantitative value (detection rate %)	 	in R0	in R50	in WF0	in WF50	 	C1	bis(5'-adenosyl)-triphosphatase isoform X1	FHIT	XP_011954617.2	17 kDa	Chi-square	0.0117	N.D. (0%)	6.5 (50%)	5.76 (75%)	7.3 (100%)	 	beta-glucuronidase	GUSB	XP_027817734.1	74 kDa	Chi-square	0.0019	N.D. (0%)	6.88 (100%)	6.18 (50%)	6.6 (100%)	 	vesicle-associated membrane protein-associated protein B/C	VAPB	XP_017913111.1	27 kDa	ANOVA	0.00037	6.56	7.49	7.57	7.7	 	transthyretin precursor	TTR	NP_001009800.1	16 kDa	ANOVA	0.0028	8.33	8.55	8.58	9.17	 	C2	aflatoxin B1 aldehyde reductase member 2	AKR7A2	XP_027821430.1	41 kDa	Chi-square	0.0070	6.76 (75%)	7.03 (100%)	N.D. (0%)	7.21 (100%)	 	inactive hydroxysteroid dehydrogenase-like protein 1	HSDL1	NP_001092341.1	37 kDa	Chi-square	0.00270	6.17 (25%)	6.21 (100%)	N.D. (0%)	6.76 (75%)	 	squalene synthase isoform X2	FDFT1	XP_004004500.1	48 kDa	Chi-square	0.012	6.56 (75%)	6.63 (100%)	N.D. (0%)	6.59 (50%)	 	transportin-2 isoform X4	TNPO2	XP_027825368.1	103 kDa	Chi-square	0.003	6.32 (25%)	6.44 (75%)	N.D. (0%)	6.82 (100%)	 	C3	dermcidin isoform 1 preproprotein	DCD	NP_444513.1	11 kDa	Chi-square	0.046	5.47 (50%)	N.D. (0%)	5.94 (75%)	6.41 (75%)	 	apolipoprotein A-I	APOA1	XP_011950887.2	30 kDa	ANOVA	0.0019	9.17	9.14	9.33	9.87	 	tetranectin precursor	CLEC3B	NP_001039677.1	22 kDa	ANOVA	0,022	7.07	7.13	6.97	7.47	 	protein AMBP isoform X2	AMBP	XP_005684398.1	39 kDa	ANOVA	0,033	6.97	7.07	7.14	7.53	 	C4	thiosulfate sulfurtransferase	TST	XP_014950344.2	33 kDa	Chi-square	0.0027	6.99 (75%)	6.91 (100%)	5.87 (25%)	N.D. (0%)	 	nicastrin isoform X2	NCSTN	XP_012039753.2	67 kDa	Chi-square	0.028	6.58 (50%)	6.8 (75%)	6.68 (75%)	N.D. (0%)	 	long-chain fatty acid transport protein 1	SLC27A1	XP_027825247.1	71 kDa	ANOVA	0.0066	6.6	7.16	6.59	6.52	 	glucosidase 2 subunit beta	PRKCSH	XP_027825495.1	60 kDa	ANOVA	0.023	7.22	7.94	7.91	7.53	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>17456</offset><text>Pairwise comparisons of proteins in GCs from ewes exposed or not exposed to BPS and presenting contrasted metabolic status</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17579</offset><text>Pairwise comparisons were performed on the lists of the 958 quantified proteins (t-test p &lt;= 0.05 and FC &gt;= 2 or &lt;= 0.5; chi-square test p &lt;= 0.05; Supplementary Table S2). Figure 5 shows the distribution and overlap of DAPs between the comparisons. The different comparisons showed relatively similar number of DAPs (34 for R0 vs. R50, 26 for WF0 vs. WF50, 37 for RO vs. WF0, and 48 for R50 vs. WF50). Most of the DAPs were specific to each comparison and there was no DAP shared among all the comparisons.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18106</offset><text>The gene symbols for the DAPs were used for GO enrichment analysis of biological processes with Metascape (Supplementary Figure S1). The R50 vs. WF50 comparison highlighted a higher number of enriched biological processes compared with the other comparisons (Supplementary Figure S1D). The functional enrichments of DAPs for R0 vs. R50 is related to metabolism and detoxification (carbohydrate metabolic process and cellular detoxification) and proper functioning of the cells (intracellular protein transport, intracellular chemical homeostasis, organic anion transport, negative regulation of amide metabolic process and of cell development; Supplementary Figure S1A). The functional enrichments of DAPs for WF0 vs. WF50 is related to cells and organism balance and development (protein localisation to nucleus, negative regulation of cellular component organisation and of the immune effector process, positive regulation of cell migration, chordate embryonic development, and protein maturation) or in metabolism (alcohol and carbohydrate metabolic process; Supplementary Figure S1B). The functional enrichment of DAPs for R0 vs. WF0 is related to oxidative stress (response to reactive oxygen species) and proper cell functioning (endoplasmic reticulum membrane organisation, electron transport chain, cellular homeostasis, regulation of vesicle-mediated transport; Supplementary Figure S1C). Finally, the functional enrichment of DAPs for R50 vs. WF50 is related to metabolism (generation of precursor metabolite and energy, carbohydrate derivative biosynthetic and metabolic process and lipid modification), the immune response (regulation of leucocyte migration and defence response to bacterium) and proper cell functioning (positive regulation of substrate adhesion-dependent cell spreading, small molecule biosynthetic process, mitochondrial transmembrane transport, maintenance of location, regulation of establishment of protein localisation, homeostasis of the number of cells, response to hypoxia and negative regulation of cell adhesion).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20161</offset><text>To decipher the impact of BPS, proteomaps of the DAPs for the R0 vs. R50 and WF0 vs. WF50 comparisons were generated by using the KEGG pathways database (Fig. 6A and B). One of the common functions between both comparisons is carbohydrate metabolism, including the beta-glucuronidase (GUSB), which is present in both proteomaps. This protein was detected in all BPS-exposed ewes (the R50 and WF50 conditions), whereas it was not quantified in the R0 samples and was detected in 50% of the WF0 samples (Supplementary Table S3). Another common protein, nucleoprotein translocated promoter region (TPR) - which is involved in the processing of genetic information, more specifically in RNA transport - is also found in both proteomaps (Fig. 6A and B). This protein was more detected in R50 and WF50 (75% detection rate) compared with R0 (25% detection rate) and WF0 (0% detection rate; Supplementary Table S3). The diet effect, visualised as R0 vs. WF0 and R50 vs. WF50, showed proteins that are mainly involved in lipid and glycan metabolism, oxidative phosphorylation and purine and amino acid metabolism, including proteins like thiosulfate sulfurtransferase (TST), farnesyl-diphosphate farnesyltransferase 1 (FDFT1) and bis(5'-adenosyl)-triphosphatase (FHIT). Both TST and FDFT1 were detected more frequently in restricted than well-fed ewes (Fig. 6C and D). TST was detected in 75% and 100% of R0 and R50 samples, respectively, whereas it was detected in 25% and 0% of WF0 and WF50 samples, respectively. Similarly, FDFT1 was detected in 75% and 100% of R0 and R50 samples, respectively, whereas it was detected in 0% and 50% of WF0 and WF50, respectively. On the contrary, FHIT was detected in 0% and 50% of R0 and R50 samples, respectively, whereas it was detected in 75% and 100% of WF0 and WF50, respectively, and was therefore found more often in well-fed ewes than in restricted ewes. Interestingly, proteins involved in oxidative stress were found in the R0 vs. R50 proteomaps, namely glutathione peroxidase 7 (GPX7), and in the R0 vs. WF0 proteomaps, namely NADH dehydrogenase 1 alpha subcomplex subunit 7 (NDUFA7). GPX7 was more abundant in R50 compared with R0 (FC = 15.6) and NDUFA7 was more abundant in WF0 compared with R0 (FC = 5.6; Supplementary Table S2). Lipopolysaccharide (LPS)-binding protein (LBP), a protein involved in the NF-kappa B signalling pathway; nicastrin (NCSTN), a protein involved in the Notch signalling pathway; and apolipoprotein A1 (APOA1), a protein involved in the PPAR signalling pathway, were also found in the WF0 vs. WF50 and R50 vs. WF50 proteomaps. LBP was less abundant in WF0 compared with WF50 (FC = 0.34), and less abundant in R50 compared with WF50 (FC = 0.06). NCSTN was detected more frequently in WF0 (75%) compared with WF50 (undetected), and more frequently detected in R50 (75%) compared with WF50 (undetected). APOA1 was more abundant in WF50 compared with WF0 (FC = 2.35) and R50 (FC = 2.48). Lastly, ras-related protein Rab-5B (RAB5B) and ras-related protein Rab-5 C (RAB5C), involved in protein transport, were found in the R0 vs. R50 and R0 vs. WF0 proteomaps. They were more abundant in R50 (FC = 2.45 and 3.10, respectively) and WF0 (FC = 3.23 and 3.84, respectively) compared with R0.</text></passage><passage><infon key="file">12864_2024_11034_Fig5_HTML.jpg</infon><infon key="id">Fig5</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>23461</offset><text>Comparative analysis of differentially abundant proteins identified in ewes Granulosa Cells</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>23553</offset><text>Venn diagram shows the overlap of the DAPs from the pairwise comparisons (p-value t-test &lt;= 0.05 and fold change ratio Log2(FC) &gt;= 1 or &lt;= -1; feed x BPS exposure) and histogram representing the number of proteins identified in each condition.</text></passage><passage><infon key="file">12864_2024_11034_Fig6_HTML.jpg</infon><infon key="id">Fig6</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>23808</offset><text>Proteomaps of differentially abundant proteins in R0 vs. R50 (A) and WF0 vs. WF50 (B), R0 vs. WF0 (C) and R50 vs. WF50 (D)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>23931</offset><text>Protein maps were generated using the KEGG (Kyoto Encyclopedia of Genes and Genomes) Pathway gene classification. Proteomaps were created from the average of the quantification values of the overabundant or most detected DAPs in each pairwise comparison with a Log2(FC) &gt;= 1 or &lt;= -1 minimum. In the left column, functional categories are represented by polygons, and in the right column, proteins are represented by the same polygons. The polygons illustrate the normalised abundance of proteins in each condition. Functions and related proteins are organised into common regions and coded using similar colours.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>24551</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24562</offset><text>This study aimed to characterise the effects of chronic BPS exposure on the proteome of ewe GCs, considering the interaction between metabolism status and reproductive function. Even though some deleterious impacts of BPS on GCs have already been reported in vitro, this is the first study to characterise the GC proteome after chronic BPS exposure. Furthermore, this study compared the BPS effects on the GC proteome in ewes with a contrasted metabolic status. These results have highlighted the interaction between metabolism and BPS exposure by identifying specific proteins in each comparison. In addition, proteins related to the BPS effect were also identified, in particular GUSB, which was significantly overexpressed in the GCs of BPS-exposed compared with non-exposed ewes. Because GUSB is able to remove the glucuronide conjugate from bisphenol molecules and thus to restore the oestrogenic activity of bisphenols, it could worsen the effects of this exposure.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>25534</offset><text>BPS - metabolism interaction</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25569</offset><text>Chronic BPS exposure of adult ewes affected the GC proteome; and its effects varied depending on the metabolic status of the ewes. Most of the DAPs and predicted pathways and functions were specific to one comparison. According to the Venn diagram, only 5 common proteins were identified between the R0 vs. WF0 and R50 vs. WF50 comparisons (diet effect). On the contrary, 21 proteins were identified specifically for the R0 vs. WF0 condition and 30 for the R50 vs. WF50 condition. Therefore, most of the proteins corresponding to the diet effect (21 and 30 proteins) differ depending on the BPS exposure. Similarly, for the BPS effect, 6 proteins common to the R0 vs. R50 and WF0 vs. WF50 comparisons (BPS effect) were identified. On the contrary, 14 proteins were identified specifically for the R0 vs. R50 comparison and 9 for the WF0 vs. WF50 comparison, again suggesting that the 14 and 9 proteins differ depending on diet. This highlighted the interaction between the BPS effect and metabolic status. In addition, the interaction between BPS exposure and the metabolic status was also highlighted by the unexpected common DAPs shared between pairwise comparisons mixing BPS and diet effects. Indeed, there were 9 common DAPs between the R0 vs. R50 (BPS effect) and R0 vs. WF0 (diet effect) comparisons, and 9 common DAPs between the WF0 vs. WF50 (BPS effect) and R50 vs. WF50 (diet effect) comparisons. These results strengthen our hypothesis that the effects of BPS differed according to body condition, which is in line with the analyses previously performed on these same ewes as part of the same study. This interaction might be specific to ovarian cell functioning as it was not reported when studying oviduct proteome in the same ewes, the diet effect being the main effect observed. Modulation of the BPS effect by the metabolic status has already been highlighted regarding the oestradiol content in the preovulatory follicular fluids from the same follicles that provided the GCs for the present proteomic analysis. Indeed, after BPS exposure, the oestradiol level increased in well-fed ewes, while it did not change in restricted ewes. Moreover, in vitro embryo production with oocytes punctured during the previous oestrous cycles of the same ewes showed that, even though there was no BPS effect on the embryo parameters, there was a BPS x diet interaction, suggesting that the BPS effect differs according to the metabolic status. Other studies on the effects of synthetic chemicals such as BPA, phthalates and microplastics have also shown the importance of considering the metabolic status when studying exposure to environmental pollutants. In rodents, exposure to BPA through intragastric gavage or oral administration combined with a high-fat diet (particularly butter) led to transgenerational dysfunction of the entire reproductive system, including an altered oestrous cycle and disrupted spermatogenesis in rats compared with a low-fat diet or a high-fat olive oil diet. Moreover, a study on di(2-ethylhexyl) phtalate (DEHP) oral exposure, at a dose considered safe in the environment, combined with a high-fat diet in pregnant mice suggested a negative effect on the development of placental vascularisation and foetal growth compared to a regular diet. Similarly, in rats the combination of a high-fat diet and DEHP exposure had joint effects on lipid metabolism. Another study showed that oral exposure of pregnant mice to a perfluorooctanesulfonic acid (PFOA) and per- and polyfluoroalkyl substances (PFAS) mixture (PFOA/perfluorooctane sulfonate (PFOS)/perfluorohexanesulfonate (PFHxS)), combined with high-fat diet, could influence the effect of PFAS on the liver of their offspring, and could render them more sensitive to the perinatal effects of PFAS.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>29358</offset><text>APOA1 is the main component of high-density lipoprotein and plays an important role in reverse transport of cholesterol, which is the precursor molecule for steroidogenesis. LBP is involved in the immune response to LPS by promoting an inflammatory response through the initiation of an inflammatory cytokine cascade which mediates the elimination of LPS. Both proteins are involved in anti-inflammatory or immune functions. Even though the balance between both molecules is not clearly stated in the literature, LBP is increased in exacerbated lipid metabolism environment while APOA1 is reduced, which is consistent with the present study with APOA1 being increased when LBP is decreased and vice versa. In contrast to APOA1, LBP was overabundant in R50 and WF0 compared with WF50 (FC = 16.22 and 2.93, respectively), which is not consistent with the literature. Indeed, a high-fat and high-carbohydrate meal has been reported to increase the human plasma LBP concentration, but this phenomenon did not occur in the present study since LBP protein was overabundant in R ewes compared with WF ewes when exposed to BPS. This could be explained by the fact that LBP reduces circulating LPS levels especially through the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) pathway. Indeed, activation of NF-kappaB by LPS treatment (leading to an increase in LBP) significantly reduced APOA1 in HepG2 cells in vitro, while NF-kappaB inhibition in mice increased plasma APOA1 in vivo. This balance between APOA1 and LBP is involved in both diet and BPS exposure effect, as both APOA1 and LBP were found in WF0 vs. WF50 and R50 vs. WF50 comparison. Furthermore, it has been reported that BPS activates NF-kappaB and BPA inhibits APOA1 in mouse hepatocytes, which is opposite compared with the present study. NF-kappaB inhibition increases plasma APOA1 through activation of Peroxisome Proliferator-activated Receptor alpha. In fact, our results suggested that BPS exposure and WF diet upregulate APOA1 and downregulate LBP protein. These results could be due to the activation of the NF-kappaB pathway by the interaction of metabolism and BPS exposure, leading to a decrease in LBP and an increase in APOA1. The mechanism through which BPS affects NF-kappaB pathway requires further investigation. This study has highlighted that the metabolic status should be considered when studying the effects of environmental factors so that their potential effects in subgroups of the population are not underestimated.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>31886</offset><text>Metabolism effect</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>31904</offset><text>PCA showed a clear discrimination of DAPs according to the metabolic status. There were only 5 common proteins between the R0 vs. WF0 and R50 vs. WF50 comparisons: TST, FHIT and FDFT1, which are involved in metabolism, and CDH6 and DCD, which are involved in cell function. FHIT had a significantly higher detection rate in the GCs of well-fed ewes compared with restricted ewes. This finding is in line with papers establishing a link between the FHIT gene in humans and BMI and waist circumference, and that it is correlated with adiposity in adulthood. FDFT1, also known as squalene synthase (SQS), is the first specific enzyme in cholesterol biosynthesis. FDFT1 was detected more frequently in GCs of restricted ewes. FDFT1 hepatic messenger RNA (mRNA) levels are regulated by the cholesterol status. In fact, FDFT1 enzyme activity and protein and mRNA levels can decrease dramatically in response to cholesterol overabundance and increase sharply in response to cholesterol deprivation in both animals and cultured hepatic cells. FHIT and FDFT1 were detected in most BPS-exposed ewes (regardless of the diet) but much less frequently or not at all in the unexposed ewes. These findings highlight the potential involvement of BPS in adiposity and/or lipid metabolism. Indeed, in vitro and in vivo studies showed that BPS could promote obesogenic effect and metabolic disorders, and promote adipogenesis in human preadipocytes. Although our experiment was not designed to observe obesogenic effects, additional studies should include such parameters.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>33458</offset><text>In addition, the basic protein profile of GCs is very metabolically oriented as shown by the proteomaps. After several months of restricted feeding, basic requirements have likely been reduced to a minimum due to the energy deficit. This is in line with the lower NEFA level in R0 ewes, indicating that these ewes, contrary to the beginning of the diet restriction, did not have the body reserve to compensate for the lower energy intake relative to the energy requirement. The metabolic functions involved in the R50 vs. WF50 comparison include lipid, carbohydrate and energy metabolism, and most of the proteins involved in these functions were overabundant or detected more frequently in R50 compared with WF50, including ATP5A1 and ATP5B involved in adenosine triphosphate (ATP) production, as a means to compensate for the low energy intake. Similarly, in a previous study of bovine GCs, the authors found that most DAPs (259 total DAPs among 3,409 identified proteins) from the dominant vs. subordinated follicle comparison are also involved in metabolic pathways, according to KEGG pathway analysis. Therefore, metabolism, including lipid metabolism, is expected to be crucial for the correct maturation of oocytes. Modulations of lipid metabolism could also impair the ability of GCs to perform their functions as previously reported in bovine GCs. A comparative study of the fatty acid composition of oocyte lipids in cattle and sheep showed that these two ruminant species are close in terms of lipid metabolism. Lipid metabolism is therefore likely crucial in ovine GCs and oocytes too.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>35056</offset><text>Oxidative stress proteins such as GPX7 and NDUFA7, both involved in regulating the redox status, were overabundant in the R50 and WF0 ewes compared with R0 ewes, respectively. This suggests that the R0 condition led to an inhibition of the antioxidant response. Undernourishment in pregnant ewes alters the expression of the glutathione peroxidase genes in the blood and liver of the mother and in the foetus at the end of gestation. Additional data are required to compare pregnant and non-pregnant ewes and to investigate the link between oxidative stress and food restriction.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>35636</offset><text>BPS effect</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>35647</offset><text>BPS had a moderate effect in terms of the number of DAPs in the GCs proteome. These changes are relevant when considering the results of the embryo production and steroidome study of the same ewes. In fact, BPS alone only results in a moderate number of DAPs, and the interaction between BPS exposure and diet produced more DAPs. Nevertheless, the in vivo model is still more sensitive compared with in vitro experiments. Indeed, after chronic daily in vivo oral exposure to 50 microg/kg/day BPS, corresponding to a follicular fluid concentration of 200 nM BPS (measured as BPS-g) on average, there were changes in oestradiol secretion in the follicular fluid. However, there were no differences in steroidogenesis after acute exposure up to 1 microM BPS in vitro in the same species. It is interesting to note that the most outstanding functions in the proteomaps corresponding to the BPS effects are related to energy, glycan, carbohydrate, amino acid, lipid and steroid metabolism; the processing of genetic information, including RNA transport; and cellular processes. Studies on human cohorts have shown that exposure to BPS could be associated with elevated BMI and waist circumference, based on median urinary concentrations, and therefore related to changes in energy metabolism. In addition, significant disturbances in lipid and glucose metabolism, as well as an increase in fat accumulation due to BPS, were reported in the preadipocytic 3T3-L1 cell lines in vitro. Indeed, BPS is a potent chemical responsible for the hyperglycaemic response and also alters many metabolites by hampering various biological pathways. A metabolomic pathway analysis revealed an alteration in glycolysis or gluconeogenesis pathway upon BPS exposure in rats. The possible mechanisms of action are attributed to oestrogenic or androgenic activities, favouring alterations in the genetic expression of markers linked to adipogenesis and inducing oxidative stress and an inflammatory state. Of note, BPS binds to oestrogen but not to androgen receptors.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>37690</offset><text>There were six common DAPs when comparing BPS-exposed ewes to their respective unexposed controls (R50 vs. R0 or WF50 vs. WF0) including GUSB, involved in metabolism, and HSDL1, TNPO2 and TPR, involved in the proper functioning of the cell. GUSB degrades glycosaminoglycans and participates in the degradation of polysaccharides that contain glucuronide residues. GUSB helps to deconjugate various potential toxins, hormones, and various drugs in the body and is also involved in hydrolysis of glucuronides of endo- and xenobiotics in humans. GUSB has already been reported to hydrolyse conjugated BPA into free BPA as it passes through the placental barrier. While BPS-g is unable to bind to oestrogen receptors, it is still able to exert effects on cells, and sometimes the effect is even worse compared with free BPA. Therefore, the higher abundance of GUSB in the GCs from BPS-exposed ewes suggested that metabolised BPS-g could be deconjugated into free BPS in the follicular compartment, leading to prolonged intracellular exposure to free BPS and to prolonged oestrogenic effects. Such a conversion cycle of bisphenol has not previously been described at ovarian level. Exposure to BPS likely worsens this potential effect at the ovarian level. In the present study, GUSB was not upregulated in WF50 ewes compared with R50 ewes. Nevertheless, GUSB activity in serum and plasma has been associated with higher BMI in humans. It is important to note that in some of those studies, the BMI is closer to overweight than to obesity (i.e. it does not exceed 26.5 kg/m2). In another study of menopausal and premenopausal women, GUSB activity was also positively correlated with fat mass but not with lean mass and therefore with individual adiposity which is consistent with our results. Indeed, even if GUSB is not upregulated in WF0 compared to R0, it was detected in half of the samples in WF0 samples while it was never detected in the R0 sample. GUSB was therefore found in well-fed ewes, whether exposed to BPS or not, unlike in restricted ewes. It could thus be assumed that R0 corresponded to the condition exhibiting the lowest expression. As mentioned before, despite their diet, the WF50 ewes could not be considered obese (their mean BCS was 2.88). It is possible that a further increase in GUSB could be observed in obese individuals exposed to BPS, which would exacerbate exposure to free BPS in this population and, consequently, overfeeding would exacerbate the negative effects of BPS exposure. Additional studies should assess this hypothesis because its confirmation would suggest a higher sensitivity of women with obesity to bisphenol exposure.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>40357</offset><text>Limitations of the study</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>40382</offset><text>One of the limitations of this study is that GCs were collected with follicular fluid, which is a plasma ultrafiltrate. Therefore, blood proteins were very abundant and could potentially have masked the signal of less abundant proteins, resulting in fewer quantified proteins. In addition, serum albumin was not depleted before analysis to avoid eliminating potential albumin-binding proteins. Another limitation of this study is that the two diets used in this study were either abnormally restrictive or abnormally excessive, so neither group of ewes received 100% of their dietary requirements. Furthermore, as mentioned above, well-fed ewes with a mean BCS of 2.88 cannot be considered as obese, despite their elevated plasma NEFA and glucose levels. Consequently, the hypotheses put forward should be interpreted with caution and additional tests should be carried out on animals with a BCS of 4. It is difficult to discuss whether an obese phenotype would worsen the BPS effects. Nevertheless, given these limits, our data suggest that the effects of BPS exposure could vary depending on the metabolic status of the ewes and the involved energy metabolism.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>41545</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>41556</offset><text>Chronic exposure of adult ewes to BPS affected the GC protein content, and this effect was modulated by the metabolic status of the animals. A total of 958 proteins were quantified and 59 were differentially abundant in the four experimental groups. In addition, various functional pathways were affected, mainly energy metabolism pathways. GUSB was identified in the GC proteome of BPS-exposed animals. Moreover, among unexposed ewes, GUSB was detected only in well-fed ewes. GUSB could increase BPS exposure by deconjugating BPS-g into free BPS. This protein might worsen or prolong the exposure of these cells to free BPS, therefore prolonging oestrogenic effects that might be even further worsened in people with adiposity. It is difficult to discuss whether the well-fed phenotype worsens the BPS effects, as there are only few studies examining the interaction between BPS exposure and adiposity in vivo and there is no diet group corresponding to normal feeding. Here, leads are suggested but require deeper investigation. Nevertheless, the data showed, in WF ewes exposed to BPS, an alteration in in vitro embryo production, in GC steroidogenesis with increased levels of oestradiol in the follicular fluid and in GC proteomics, in particular GUSB abundance. All these data suggested a potentially higher sensitivity to the effects of BPS in adipose individuals. These results and those of previous studies highlight the deleterious effect of BPS and its interaction with the metabolic status, indicating that its use in food packaging should be regulated.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>43122</offset><text>Materials and methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>43144</offset><text>Ethics</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>43151</offset><text>All experimental procedures were conducted in accordance with the European Directive 2010/63/EU on the protection of animals used for scientific purposes and approved by the French Ministry of Nation Education, Higher Education, Research and Innovation after ethical assessment by the local ethics committee Comite d'Ethique en Experimentation Animale Val de Loire (CEEA VdL) and INRAE consented to use the animals in this experimental protocol (protocols registered under APAFIS numbers 13965-2018042008519239v2 and 14014-2018030717477406v2).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>43699</offset><text>Experimental design</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>43719</offset><text>A total of 40 primiparous Ile-de-France ewes (average age 2.5 years) were housed in a sheepfold from 2018 to 2019. The experimental design was described previously. Briefly, the ewes were divided into two groups with contrasting diets: restricted (R, n = 20) and well-fed (WF, n = 20). The diet was designed according to the INRAE recommendations for the growth and maintenance needs of adult, non-pregnant ewes. It consisted in varying the quantity of a wheat-based food supplement (Agneau-echange, AXEREAL Elevage, Saint Germain de Salles, France). The food supplement was distributed in the morning and the animals had free access to straw and water and minerals to lick. Ewes from the experiment groups were fed in order to reach the goal of a median BCS of 2 in restricted groups and of 4 in well-fed groups and the quantity was adjusted according to the mean of body weight of the group. Ewes in the restricted group were initially fed 50% of their maintenance energy requirements and, once the target BCS was reached, they were fed 80% in order to maintain the desired nutritional status. Ewes in the WF groups were fed 165% of their maintenance energy requirements until the end of the experiment. The BW (kg) and BCS (on a scale of 1 to 5, 1 corresponding to very skinny ewes and 5 to obese ewes) of animals were monitored once a month. Within each group, two subgroups were defined according to BPS exposure (0-50 microg/kg/day) for at least 3 month, 5.4 +- 0.1 months (range: 3.6-7.9 months. The BPS, purchased from Sigma Aldrich (Madrid, Spain), was added to the feed in the form of a powder mixed with the cereals. Thus, there were four groups: R0 and R50 for the restricted ewes, and WF0 and WF50 for the well-fed ewes. Between September and December, the oestrus cycle of the 40 ewes was synchronised with a vaginal sponge of progesterone (Chrono-Gest  20 mg, MSD, Beaucouze, France) for 11 days, followed by intramuscular administration of pregnant mare serum gonadotropin (PMSG, Synchro-Part  PMSG 400 IU, CEVA Sante Animale, Libourne, France). Two days after PMSG administration, at the presumed time of the pre-ovulatory period, the ewes were slaughtered, and follicular cells of the dominant follicles were collected by aspirating the follicular fluid containing GCs. GCs were centrifuged and washed twice with phosphate-buffered saline (PBS) and then stored dry at -80  C until analyses. Blood samples (5 mL) were collected at the time of slaughterhouse bleeding in heparinised tubes (17 IU/mL sodium heparin, Vacutainer ; Becton Dickinson and Company, Le Pont de Claix, France), centrifuged (3,700 g for 30 min at 4  C) and plasma samples were stored at -20  C for further assay of glucose, NEFA, BPS and its metabolite BPS-glucuronide (BPS-g).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>46513</offset><text>Plasma glucose, non-esterified fatty-acids BPS and BPS-glucuronide assays</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>46587</offset><text>Plasma glucose and NEFA were quantified individually (n = 80) on a 2 and 5 microL undiluted plasma sample, respectively, by colorimetric enzymatic methods using a Konelab 20 analyzer (Thermo Scientific, Gometz le Chatel, France) and kits provided by Bio-Merieux (Marcy-l'Etoile, France) and Thermo Scientific (Villebon sur Yvette, France). BPS and BPS-g concentration were quantified as previously describe using liquid chromatography mass spectrometry with an Acquity U-HPLC device coupled to a Xevo-TQ triple quadrupole mass spectrometer (Waters, SaintQuentin-en-Yvelines, France) operated with positive electrospray ionization and MRM mode. All samples were quantified on the same day. The limit of quantification (LOQ) was set at 0.5 ng/mL (2 nM) for BPS and 0.05 ng/mL (0.10 nM) for BPS-g.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>47387</offset><text>Protein extraction and quantification</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>47425</offset><text>The GC pellet was resuspended on ice with 100 microL of lysis buffer (10 mM Tris-HCl + 2% sodium dodecyl sulphate [SDS] + 1X protease inhibitor). Then, it was sonicated (2 x 20 s, five times for each sample) and centrifuged (30 min, 10000 g, 4  C). The supernatant was transferred to a new tube kept on ice and stored at -20  C. The protein concentration was quantified using the colorimetric BC assay Protein Quantification kit (Interchim, Montlucon, France), following the manufacturer's recommendations. The optical density at 550 nm was measured with a Thermo LabSystems plate reader at 550 nm absorbance and with Ascent software for Multiskan equipment.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>48105</offset><text>Preparation of GC samples for comparative proteomic analyses</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>48166</offset><text>After protein extraction and quantification, 50 microg of protein per sample was separated with 4-10% SDS-polyacrylamide gel electrophoresis (80 V, 10 min and 180 V, 50 min). After separation, the gel was stained with Coomassie blue. It was cut into four strips for each track and washed in water and acetonitrile (1:1 [v/v], 5 min) followed by 100% acetonitrile (10 min). Reduction and cysteine alkylation were performed by successive incubation with 10 mM dithiothreitol in 50 mM ammonium bicarbonate (30 min, 56  C), then 55 mM iodoacetamide in 50 mM ammonium bicarbonate (20 min, room temperature, in the dark). The pieces were incubated with 50 mM ammonium bicarbonate with acetonitrile (1:1 [v/v], 10 min) followed by acetonitrile (15 min). Proteolytic digestion was carried out overnight using 25 mM ammonium bicarbonate containing 12.5 ng/microL trypsin (sequencing grade, Roche Diagnostics, Paris, France). The resultant peptides were extracted by incubation in 5% formic acid (with sonication). The supernatant was removed and incubated with acetonitrile and 1% formic acid (1:1 [v/v], 10 min). After a final incubation with acetonitrile (5 min), the supernatant was removed and saved. These two peptide extractions were pooled and dried using a SPD1010 SpeedVac system (Thermosavant, Thermofisher Scientific, Bremen, Germany).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>49513</offset><text>NanoLC-MS/MS</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>49526</offset><text>Peptide mixtures were analysed with on-line nanoLC-MS/MS as described previously. All experiments were performed on a dual linear ion trap Fourier-transform mass spectrometer (FT-MS) LTQ Orbitrap Velos Pro (Thermo Fisher Scientific, Bremen, Germany) coupled to an Ultimate  3000 RSLC Ultra High-Pressure Liquid Chromatographer (Thermo Fisher Scientific, Bremen, Germany) controlled by Chromeleon Software (version 6.80 SR13). The samples were desalted and concentrated for 10 min at 5 microL/min on an LCPackings trap column (Acclaim PepMap 100 C18, 75 mum inner diameter x 2 cm long, 3 mum particles, 100 A pores). The peptide separation was conducted using a LCPackings nano-column (Acclaim PepMap C18, 75 mum inner diameter x 50 cm long, 2 mum particles, 100 A pores) at 300 nL/min by applying a gradient of 2-45% B over 90 min. The mobile phases consisted of 0.1% formic acid, 97.9% water and 2% acetonitrile (v/v/v; A), and 0.1% formic acid, 19.9% water, 80% acetonitrile (v/v/v; B). The data were acquired using Xcalibur version 3.0.63 software (Thermo Fisher Scientific, San Jose, CA), in positive data-dependent mode in the 300-1800 m/z mass range. The resolution in the Orbitrap was set at R = 60,000. The 20 most intense peptide ions with charge states &gt;= 2 were isolated sequentially (isolation width 2 m/z, 1 microscan) and fragmented in the high-pressure linear ion trap using the collision induced dissociation (CID) mode (collision energy 35%, activation time 10 ms, Qz 0.25). Dynamic exclusion was activated for 30 s with a repeat count of 1. The lock mass was enabled for accurate mass measurements. The polydimethylcyclosiloxane ((Si(CH3)2O)6, m/z 445.120025) ion was used for internal recalibration of the mass spectra MS/MS.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>51295</offset><text>Protein identification and data validation</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>51338</offset><text>Ion searches were performed using the Mascot search engine version 2.7.0.1 (Matrix Science, London, UK) via the Proteome Discoverer 2.5 software (ThermoFisher Scientific, Bremen, Germany) against the NCBI prot_Mammals database (2021/07). The search parameters included trypsin as the protease with two allowed missed cleavages and carbamidomethyl cysteine, methionine oxidation and acetylation of the N-terminal protein as variable modifications. The tolerance of the ions was set to 5 ppm for parent and 0.8 Da for-fragment ion matches. The Mascot results obtained from the target and decoy databases searches were analysed with the Scaffold Q + S v5.1.1 and Scaffold Quant v5.0.3 softwares (Proteome Software, Portland, OR, USA) using the protein cluster analysis option (assemblage of proteins into clusters based on shared peptide evidence). Peptide and protein identifications were accepted if they could be established with a probability of &gt; 95%, in accordance with the Peptide Prophet and the Protein Prophet algorithms, respectively. Proteins were identified with a minimum of two unique peptides. Extracted ion chromatogram (XIC) is based on the normalised values of the intensities of the chromatographic peaks corresponding to the peptides of a protein. XIC data were log transformed (log10 precursor intensity). The names of clusters, redundant proteins, and potential contaminants (keratin from Homo sapiens and trypsin) were excluded from the lists. In addition, only Homo sapiens and the followed herbivorous species were retained: Ovis aries, Ammotragus lervia, Bison bison bison, Bos indicus, Bos indicus x Bos taurus, Bos javanicus, Bos mutus, Bos taurus, Bubalus bubalis, Camelus bactrianus, Camelus dromedarius, Camelus ferus, Capra hircus, Cervus elaphus, Cervus elaphus hippelaphus, Cervus hangul yarkandensis, Equus asinus, Equus caballus, Equus przewalskii, Muntiacus muntjac, Muntiacus reevesi, Muntiacus vaginalis, Odocoileus virginianus texanus, Odocoileus virginianus virginianus, Ovis canadensis nelson, and Vicugna pacos.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>53398</offset><text>Drawing up a list of differentially abundant proteins (DAPs)</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>53459</offset><text>Regarding the proteins detected in all conditions, DAPs were identified after analysis of variance (ANOVA) on protein abundance (p &lt;= 0.05) and t-test (p &lt;= 0.05), when the fold-change (FC) between the two conditions was &gt;= 2 or &lt;= 0.5. Regarding the proteins present in one condition but not in the other, DAPs were identified after the chi-square test on the protein detection rate (p &lt;= 0.05). Briefly, proteins were considered to be present in a biological sample when they were detected at least once in one of the three technical replicates. Proteins that were not detected in any biological replicate for a condition were tested using the chi-square test for the bisphenol effect (proteins quantified for exposed and unexposed animals regardless of diet) and the effect of diet (proteins quantified for restricted and well-fed animals regardless of BPS exposure), but also for pairwise analyses (R0 vs. R50, WF0 vs. WF50, R0 vs. WF0, and R50 vs. WF50). This yielded 17 proteins with a p &lt;= 0.05 (chi-square test) for at least one of the comparisons (dose, diet or pairwise) and an average abundance (log10 precursor intensity) ranging from 5.94 to 7.58. For pairwise analyses, proteins with significant differences in the detection rate according to bisphenol exposure were added to the lists of DAPs for the R0 vs. R50 and WF0 vs. WF50 comparisons; likewise, proteins exhibiting significant differences in the detection rate according to diet effect were added to the lists of DAPs for the R0 vs. WF0 and R50 vs. WF50 comparisons. Proteins that responded only to the pairwise analysis (R0 vs. R50, WF0 vs. WF50, R0 vs. WF0, or R50 vs. WF50) were added to the corresponding DAPs lists.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>55178</offset><text>Principal component analysis (PCA) was performed and a heatmap was generated by using the Rstudio software (version 2023.03.0 + 386). PCA on DAPs (both ANOVA and the chi-square test) were carried out using the FactoMineR and ggplot2 packages. The percentage on each axis (dimension) represents the total variance of data according to dimension 1 (horizontal axis) and dimension 2 (vertical axis). Heatmap and hierarchical clustering on DAPs (both ANOVA and chi-square test p &lt; 0.05) were performed using the gplots package. For DAPs from the ANOVA, missing values (in one replicate among detected values in other replicates of the condition) were treated with the missMDA package. For DAPs from the chi-square test, missing values (in all replicates of a condition) were deliberately replaced by '1' because the XIC data were log-transformed (log10 precursor intensity), indicating the absence of detection.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>56098</offset><text>Functional analysis and prediction of biological processes of DAPs</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>56165</offset><text>The overlaps of DAPs between the different conditions was visualised using the online tool jvenn (https://jvenn.toulouse.inrae.fr/app/example.html). Gene enrichment analysis was performed separately for each pairwise comparison. Because the O. aries genome contains less information than the H. sapiens genome, the latter was used as preferential database for functional analyses. Gene lists of DAPs were used as input into the Database for Annotation, Visualisation and Integrated Discovery (DAVID version 2021) for Gene Ontology (GO) analysis. GO terms associated with over-represented biological processes (p &lt; 0.05) were considered significant. The Metascape Enrichment analysis tool was used to study the potential roles of DAPs (https://metascape.org/). The Kyoto Encylopedia of Genes and Genomes (KEGG) pathways associated with 958 quantified proteins and DAPs from the pairwise comparisons were investigated using the Proteomaps software (http://bionic-vis.biologie.uni-greifswald.de/). For each comparison, proteomaps were created from the highest log10 precursor intensity values of the overabundant DAPs in each pairwise comparison with a minimum FC &gt;= 2 or &lt;= 0.5. For the proteins quantified, proteomaps were generated by using the highest value from the four groups (R0, R50, WF0 and WF50).</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>57482</offset><text>Electronic supplementary material</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>57516</offset><text>Below is the link to the electronic supplementary material.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>57576</offset><text>Publisher's note</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>57595</offset><text>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>57714</offset><text>Marie-Emilie Lebachelier de la Riviere and Ophelie Teteau contributed equally to this work.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>57808</offset><text>Author contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>57829</offset><text>S.E. conceptualised the project, acquired and administrated the funding, S.E. and M.S.D. designed the methodology, and A.B. and S.E. supervised the work. O.T., O.L., A.D., S.U., P.P., D.T., V.L., V.M. and M.S.D. carried out the investigation, M-E.L.D.L.R., C.M., D.T. and V.L. were involved in data curation, and the formal analysis was made by M-E.L.D.L.R., D.T. and V.L. After the software exploitation by M-E.L.D.L.R., M-E.L.D.L.R., C.M., D.T., V.L. and M.S.D. proceeded to validation. M-E.L.D.L.R. and S.E. wrote the original draft; all the authors read, edited and approuved the manuscript.</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">title</infon><offset>58425</offset><text>Funding</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">paragraph</infon><offset>58433</offset><text>This research was financed by INRAE, &quot;Centre Val de Loire&quot; Region (BEMOL project, APR IR 2017-00117108; PERFECT project, APR IR 2021-00144784), the French National Research Agency (MAMBO, project ANR-18-CE340011-01). The high-resolution mass spectrometer was financed (SMHART project, 35069) by the European Regional Development Fund (ERDF), the Conseil Regional du Centre, the French National Institute for Agricultural Research (INRAE) and the French National Institute of Health and Medical Research (Inserm).</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>58951</offset><text>Data availability</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>58969</offset><text>Proteomic mass spectrometry data were submitted to the ProteomeXchange Consortium via the PRIDE partner repository with the identifier PXD047107.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>59115</offset><text>Declarations</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>59128</offset><text>Ethical approval and consent to participate</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>59172</offset><text>All experimental procedures were conducted in accordance with the European Directive 2010/63/EU on the protection of animals used for scientific purposes and approved by the French Ministry of Nation Education, Higher Education, Research and Innovation after ethical assessment by the local ethics committee Comite d'Ethique en Experimentation Animale Val de Loire (CEEA VdL) and INRAE consented to use the animals in this experimental protocol (protocols registered under APAFIS numbers 13965-2018042008519239v2 and 14014-2018030717477406v2).</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>59720</offset><text>Consent for publication</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>59744</offset><text>Not applicable.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>59760</offset><text>Competing interests</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>59780</offset><text>The authors declare no competing interests.</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title</infon><offset>59824</offset><text>Abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59838</offset><text>APOA1</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59844</offset><text>Apolipoprotein A1</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59862</offset><text>BCS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59866</offset><text>Body condition score</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59887</offset><text>BMI</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59891</offset><text>Body mass index</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59907</offset><text>BPA</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59911</offset><text>Bisphenol A</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59923</offset><text>BPS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59927</offset><text>Bisphenol S</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59939</offset><text>BPS-g</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59945</offset><text>BPS glucuronide</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59961</offset><text>BMI</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59965</offset><text>Body mass index</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59981</offset><text>BSA</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>59985</offset><text>Bovine serum albumin</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60006</offset><text>BW</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60009</offset><text>Body weight</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60021</offset><text>DAPs</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60026</offset><text>Differentially abundant proteins</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60059</offset><text>DEHP</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60064</offset><text>Di(2-ethylhexyl) phtalate</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60090</offset><text>FC</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60093</offset><text>Fold-change</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60105</offset><text>FDFT1</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60111</offset><text>Farnesyl-diphosphate farnesyltransferase 1</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60154</offset><text>FHIT</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60159</offset><text>Bis(5'-adenosyl)-triphosphatase</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60193</offset><text>GCs</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60197</offset><text>Granulosa cells</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60213</offset><text>GPX7</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60218</offset><text>Glutathione peroxidase 7</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60243</offset><text>GO</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60246</offset><text>Gene Ontology</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60260</offset><text>GUSB</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60265</offset><text>beta-glucuronidase</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60284</offset><text>LBP</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60288</offset><text>Lipopolysaccharide-binding protein</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60323</offset><text>LPS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60327</offset><text>Lipopolysaccharide</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60346</offset><text>NCSTN</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60352</offset><text>NF-kappa B signalling pathway; nicastrin</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60393</offset><text>NDUFA7</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60400</offset><text>NADH dehydrogenase 1 alpha subcomplex subunit 7</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60448</offset><text>NEFA</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60453</offset><text>Non-esterified fatty acids</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60480</offset><text>NF-kappaB</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60490</offset><text>Nuclear factor kappa-light-chain-enhancer of activated B cells</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60553</offset><text>PBS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60557</offset><text>Phosphate-buffered saline</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60583</offset><text>PCA</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60587</offset><text>Principal component analysis</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60616</offset><text>PFAS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60621</offset><text>Per- and polyfluoroalkyl substances</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60657</offset><text>PFOA</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60662</offset><text>Perfluorooctanesulfonic acid</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60691</offset><text>PFOS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60696</offset><text>Perfluorooctane sulfonate</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60722</offset><text>PMSG</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60727</offset><text>Pregnant mare serum gonadotropin</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60760</offset><text>PPARgamma</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60770</offset><text>Peroxisome proliferator-activated receptor gamma</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60819</offset><text>R</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60821</offset><text>Restricted</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60832</offset><text>RAB5B</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60838</offset><text>Ras-related protein Rab-5B</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60865</offset><text>RAB5C</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60871</offset><text>Ras-related protein Rab-5 C</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60900</offset><text>SQS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60904</offset><text>Squalene synthase</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60922</offset><text>TPR</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60926</offset><text>Translocated promoter region</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60955</offset><text>TST</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60959</offset><text>Thiosulfate sulfurtransferase</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60989</offset><text>WF</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>60992</offset><text>Well-fed</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>61001</offset><text>XIC</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>61005</offset><text>Extracted ion chromatogram</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>61032</offset><text>References</text></passage><passage><infon key="citation-alternatives">Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24(2):139-77.
</infon><infon key="fpage">139</infon><infon key="issue">2</infon><infon key="lpage">77</infon><infon key="name_0">surname:Vandenberg;given-names:LN</infon><infon key="name_1">surname:Hauser;given-names:R</infon><infon key="name_2">surname:Marcus;given-names:M</infon><infon key="name_3">surname:Olea;given-names:N</infon><infon key="name_4">surname:Welshons;given-names:WV</infon><infon key="pub-id_doi">10.1016/j.reprotox.2007.07.010</infon><infon key="pub-id_pmid">17825522</infon><infon key="section_type">REF</infon><infon key="source">Reprod Toxicol</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2007</infon><offset>61043</offset><text>Human exposure to bisphenol A (BPA)</text></passage><passage><infon key="citation-alternatives">EFSA Panel on Food Contact Materials E, Flavourings, Aids P. Scientific opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA J. 2015;13(1):3978.</infon><infon key="fpage">3978</infon><infon key="issue">1</infon><infon key="name_0">surname:Flavourings, Aids;given-names:P</infon><infon key="pub-id_doi">10.2903/j.efsa.2015.3978</infon><infon key="section_type">REF</infon><infon key="source">EFSA J</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2015</infon><offset>61079</offset><text>Scientific opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs</text></passage><passage><infon key="citation-alternatives">Kawa IA, Akbar M, Fatima Q, Mir SA, Jeelani H, Manzoor S, Rashid F. Endocrine disrupting chemical bisphenol A and its potential effects on female health. Diabetes Metabolic Syndrome. 2021;15(3):803-11.
</infon><infon key="fpage">803</infon><infon key="issue">3</infon><infon key="lpage">11</infon><infon key="name_0">surname:Kawa;given-names:IA</infon><infon key="name_1">surname:Akbar;given-names:M</infon><infon key="name_2">surname:Fatima;given-names:Q</infon><infon key="name_3">surname:Mir;given-names:SA</infon><infon key="name_4">surname:Jeelani;given-names:H</infon><infon key="name_5">surname:Manzoor;given-names:S</infon><infon key="name_6">surname:Rashid;given-names:F</infon><infon key="pub-id_doi">10.1016/j.dsx.2021.03.031</infon><infon key="pub-id_pmid">33839640</infon><infon key="section_type">REF</infon><infon key="source">Diabetes Metabolic Syndrome</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2021</infon><offset>61187</offset><text>Endocrine disrupting chemical bisphenol A and its potential effects on female health</text></passage><passage><infon key="citation-alternatives">Ma Y, Liu H, Wu J, Yuan L, Wang Y, Du X, Wang R, Marwa PW, Petlulu P, Chen X, et al. The adverse health effects of bisphenol A and related toxicity mechanisms. Environ Res. 2019;176:108575.
</infon><infon key="fpage">108575</infon><infon key="name_0">surname:Ma;given-names:Y</infon><infon key="name_1">surname:Liu;given-names:H</infon><infon key="name_2">surname:Wu;given-names:J</infon><infon key="name_3">surname:Yuan;given-names:L</infon><infon key="name_4">surname:Wang;given-names:Y</infon><infon key="name_5">surname:Du;given-names:X</infon><infon key="name_6">surname:Wang;given-names:R</infon><infon key="name_7">surname:Marwa;given-names:PW</infon><infon key="name_8">surname:Petlulu;given-names:P</infon><infon key="name_9">surname:Chen;given-names:X</infon><infon key="pub-id_doi">10.1016/j.envres.2019.108575</infon><infon key="pub-id_pmid">31299621</infon><infon key="section_type">REF</infon><infon key="source">Environ Res</infon><infon key="type">ref</infon><infon key="volume">176</infon><infon key="year">2019</infon><offset>61272</offset><text>The adverse health effects of bisphenol A and related toxicity mechanisms</text></passage><passage><infon key="citation-alternatives">You HH, Song G. Review of endocrine disruptors on male and female reproductive systems. Comp Biochem Physiol C Toxicol Pharmacol. 2021;244:109002.
</infon><infon key="fpage">109002</infon><infon key="name_0">surname:You;given-names:HH</infon><infon key="name_1">surname:Song;given-names:G</infon><infon key="pub-id_doi">10.1016/j.cbpc.2021.109002</infon><infon key="pub-id_pmid">33610819</infon><infon key="section_type">REF</infon><infon key="source">Comp Biochem Physiol C Toxicol Pharmacol</infon><infon key="type">ref</infon><infon key="volume">244</infon><infon key="year">2021</infon><offset>61346</offset><text>Review of endocrine disruptors on male and female reproductive systems</text></passage><passage><infon key="citation-alternatives">Skledar DG, Masic LP. Bisphenol A and its analogs: do their metabolites have endocrine activity? Environ Toxicol Pharmacol. 2016;47:182-99.
</infon><infon key="fpage">182</infon><infon key="lpage">99</infon><infon key="name_0">surname:Skledar;given-names:DG</infon><infon key="name_1">surname:Masic;given-names:LP</infon><infon key="pub-id_doi">10.1016/j.etap.2016.09.014</infon><infon key="pub-id_pmid">27771500</infon><infon key="section_type">REF</infon><infon key="source">Environ Toxicol Pharmacol</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="year">2016</infon><offset>61417</offset><text>Bisphenol A and its analogs: do their metabolites have endocrine activity?</text></passage><passage><infon key="citation-alternatives">Usman A, Ahmad M. From BPA to its analogues: is it a safe journey? Chemosphere. 2016;158:131-42.
</infon><infon key="fpage">131</infon><infon key="lpage">42</infon><infon key="name_0">surname:Usman;given-names:A</infon><infon key="name_1">surname:Ahmad;given-names:M</infon><infon key="pub-id_doi">10.1016/j.chemosphere.2016.05.070</infon><infon key="pub-id_pmid">27262103</infon><infon key="section_type">REF</infon><infon key="source">Chemosphere</infon><infon key="type">ref</infon><infon key="volume">158</infon><infon key="year">2016</infon><offset>61492</offset><text>From BPA to its analogues: is it a safe journey?</text></passage><passage><infon key="citation-alternatives">Chen D, Kannan K, Tan H, Zheng Z, Feng Y-L, Wu Y, Widelka M. Bisphenol Analogues Other Than BPA: environmental occurrence, human exposure, and Toxicity:A review. Environ Sci Technol. 2016;50(11):5438-53.
</infon><infon key="fpage">5438</infon><infon key="issue">11</infon><infon key="lpage">53</infon><infon key="name_0">surname:Chen;given-names:D</infon><infon key="name_1">surname:Kannan;given-names:K</infon><infon key="name_2">surname:Tan;given-names:H</infon><infon key="name_3">surname:Zheng;given-names:Z</infon><infon key="name_4">surname:Feng;given-names:Y-L</infon><infon key="name_5">surname:Wu;given-names:Y</infon><infon key="name_6">surname:Widelka;given-names:M</infon><infon key="pub-id_doi">10.1021/acs.est.5b05387</infon><infon key="pub-id_pmid">27143250</infon><infon key="section_type">REF</infon><infon key="source">Environ Sci Technol</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="year">2016</infon><offset>61541</offset><text>Bisphenol Analogues Other Than BPA: environmental occurrence, human exposure, and Toxicity:A review</text></passage><passage><infon key="citation-alternatives">Zhan W, Tang W, Shen X, Xu H, Zhang J. Exposure to bisphenol A and its analogs and polycystic ovarian syndrome in women of childbearing age: a multicenter case-control study. Chemosphere. 2023;313:137463.
</infon><infon key="fpage">137463</infon><infon key="name_0">surname:Zhan;given-names:W</infon><infon key="name_1">surname:Tang;given-names:W</infon><infon key="name_2">surname:Shen;given-names:X</infon><infon key="name_3">surname:Xu;given-names:H</infon><infon key="name_4">surname:Zhang;given-names:J</infon><infon key="pub-id_doi">10.1016/j.chemosphere.2022.137463</infon><infon key="pub-id_pmid">36470355</infon><infon key="section_type">REF</infon><infon key="source">Chemosphere</infon><infon key="type">ref</infon><infon key="volume">313</infon><infon key="year">2023</infon><offset>61643</offset><text>Exposure to bisphenol A and its analogs and polycystic ovarian syndrome in women of childbearing age: a multicenter case-control study</text></passage><passage><infon key="citation-alternatives">Amar S, Binet A, Teteau O, Desmarchais A, Papillier P, Lacroix MZ, Maillard V, Guerif F, Elis S. Bisphenol S impaired human granulosa cell steroidogenesis in Vitro. Int J Mol Sci. 2020;21(5):1821.
</infon><infon key="fpage">1821</infon><infon key="issue">5</infon><infon key="name_0">surname:Amar;given-names:S</infon><infon key="name_1">surname:Binet;given-names:A</infon><infon key="name_2">surname:Teteau;given-names:O</infon><infon key="name_3">surname:Desmarchais;given-names:A</infon><infon key="name_4">surname:Papillier;given-names:P</infon><infon key="name_5">surname:Lacroix;given-names:MZ</infon><infon key="name_6">surname:Maillard;given-names:V</infon><infon key="name_7">surname:Guerif;given-names:F</infon><infon key="name_8">surname:Elis;given-names:S</infon><infon key="pub-id_doi">10.3390/ijms21051821</infon><infon key="pub-id_pmid">32155818</infon><infon key="section_type">REF</infon><infon key="source">Int J Mol Sci</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2020</infon><offset>61778</offset><text>Bisphenol S impaired human granulosa cell steroidogenesis in Vitro</text></passage><passage><infon key="citation-alternatives">de la Lebachelier ME, Wu L, Gayet M, Bousquet M, Buron C, Vignault C, Teteau O, Desmarchais A, Maillard V, Uzbekova S, et al. Cumulative and potential synergistic effects of seven different bisphenols on human granulosa cells in vitro? Environ Pollut. 2023;330:121818.
</infon><infon key="fpage">121818</infon><infon key="name_0">surname:de la Lebachelier;given-names:ME</infon><infon key="name_1">surname:Wu;given-names:L</infon><infon key="name_2">surname:Gayet;given-names:M</infon><infon key="name_3">surname:Bousquet;given-names:M</infon><infon key="name_4">surname:Buron;given-names:C</infon><infon key="name_5">surname:Vignault;given-names:C</infon><infon key="name_6">surname:Teteau;given-names:O</infon><infon key="name_7">surname:Desmarchais;given-names:A</infon><infon key="name_8">surname:Maillard;given-names:V</infon><infon key="name_9">surname:Uzbekova;given-names:S</infon><infon key="pub-id_doi">10.1016/j.envpol.2023.121818</infon><infon key="pub-id_pmid">37182577</infon><infon key="section_type">REF</infon><infon key="source">Environ Pollut</infon><infon key="type">ref</infon><infon key="volume">330</infon><infon key="year">2023</infon><offset>61845</offset><text>Cumulative and potential synergistic effects of seven different bisphenols on human granulosa cells in vitro?</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>61955</offset><text>Paoli D, Pallotti F, Dima AP, Albani E, Alviggi C, Causio F, Dioguardi CC, Conforti A, Ciriminna R, Fabozzi G et al. Phthalates and Bisphenol A: Presence in Blood serum and follicular fluid of Italian women undergoing assisted Reproduction techniques. Toxics 2020, 8(4).</text></passage><passage><infon key="citation-alternatives">Gao C, He H, Qiu W, Zheng Y, Chen Y, Hu S, Zhao X. Oxidative stress, endocrine disturbance, and Immune Interference in humans showed relationships to serum bisphenol concentrations in a dense Industrial Area. Environ Sci Technol. 2021;55(3):1953-63.
</infon><infon key="fpage">1953</infon><infon key="issue">3</infon><infon key="lpage">63</infon><infon key="name_0">surname:Gao;given-names:C</infon><infon key="name_1">surname:He;given-names:H</infon><infon key="name_2">surname:Qiu;given-names:W</infon><infon key="name_3">surname:Zheng;given-names:Y</infon><infon key="name_4">surname:Chen;given-names:Y</infon><infon key="name_5">surname:Hu;given-names:S</infon><infon key="name_6">surname:Zhao;given-names:X</infon><infon key="pub-id_doi">10.1021/acs.est.0c07587</infon><infon key="pub-id_pmid">33496180</infon><infon key="section_type">REF</infon><infon key="source">Environ Sci Technol</infon><infon key="type">ref</infon><infon key="volume">55</infon><infon key="year">2021</infon><offset>62226</offset><text>Oxidative stress, endocrine disturbance, and Immune Interference in humans showed relationships to serum bisphenol concentrations in a dense Industrial Area</text></passage><passage><infon key="citation-alternatives">Machtinger R, Orvieto R. Bisphenol A, oocyte maturation, implantation, and IVF outcome: review of animal and human data. Reprod Biomed Online. 2014;29(4):404-10.
</infon><infon key="fpage">404</infon><infon key="issue">4</infon><infon key="lpage">10</infon><infon key="name_0">surname:Machtinger;given-names:R</infon><infon key="name_1">surname:Orvieto;given-names:R</infon><infon key="pub-id_doi">10.1016/j.rbmo.2014.06.013</infon><infon key="pub-id_pmid">25154017</infon><infon key="section_type">REF</infon><infon key="source">Reprod Biomed Online</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2014</infon><offset>62383</offset><text>Bisphenol A, oocyte maturation, implantation, and IVF outcome: review of animal and human data</text></passage><passage><infon key="citation-alternatives">Lloyd V, Morse M, Purakal B, Parker J, Benard P, Crone M, Pfiffner S, Szmyd M, Dinda S. Hormone-like effects of Bisphenol A on p53 and estrogen receptor alpha in breast Cancer cells. BioResearch open Access. 2019;8(1):169-84.
</infon><infon key="fpage">169</infon><infon key="issue">1</infon><infon key="lpage">84</infon><infon key="name_0">surname:Lloyd;given-names:V</infon><infon key="name_1">surname:Morse;given-names:M</infon><infon key="name_2">surname:Purakal;given-names:B</infon><infon key="name_3">surname:Parker;given-names:J</infon><infon key="name_4">surname:Benard;given-names:P</infon><infon key="name_5">surname:Crone;given-names:M</infon><infon key="name_6">surname:Pfiffner;given-names:S</infon><infon key="name_7">surname:Szmyd;given-names:M</infon><infon key="name_8">surname:Dinda;given-names:S</infon><infon key="pub-id_doi">10.1089/biores.2018.0048</infon><infon key="pub-id_pmid">31681507</infon><infon key="section_type">REF</infon><infon key="source">BioResearch open Access</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2019</infon><offset>62478</offset><text>Hormone-like effects of Bisphenol A on p53 and estrogen receptor alpha in breast Cancer cells</text></passage><passage><infon key="citation-alternatives">Rochester JR, Bolden AL. Bisphenol S and F: a systematic review and comparison of the hormonal activity of Bisphenol A substitutes. Environ Health Perspect. 2015;123(7):643-50.
</infon><infon key="fpage">643</infon><infon key="issue">7</infon><infon key="lpage">50</infon><infon key="name_0">surname:Rochester;given-names:JR</infon><infon key="name_1">surname:Bolden;given-names:AL</infon><infon key="pub-id_doi">10.1289/ehp.1408989</infon><infon key="pub-id_pmid">25775505</infon><infon key="section_type">REF</infon><infon key="source">Environ Health Perspect</infon><infon key="type">ref</infon><infon key="volume">123</infon><infon key="year">2015</infon><offset>62572</offset><text>Bisphenol S and F: a systematic review and comparison of the hormonal activity of Bisphenol A substitutes</text></passage><passage><infon key="citation-alternatives">Pelch KE, Li Y, Perera L, Thayer KA, Korach KS. Characterization of estrogenic and androgenic activities for Bisphenol A-like Chemicals (BPs): in Vitro Estrogen and Androgen receptors Transcriptional activation, Gene Regulation, and binding profiles. Toxicol Sci. 2019;172(1):23-37.
</infon><infon key="fpage">23</infon><infon key="issue">1</infon><infon key="lpage">37</infon><infon key="name_0">surname:Pelch;given-names:KE</infon><infon key="name_1">surname:Li;given-names:Y</infon><infon key="name_2">surname:Perera;given-names:L</infon><infon key="name_3">surname:Thayer;given-names:KA</infon><infon key="name_4">surname:Korach;given-names:KS</infon><infon key="pub-id_doi">10.1093/toxsci/kfz173</infon><infon key="pub-id_pmid">31388671</infon><infon key="section_type">REF</infon><infon key="source">Toxicol Sci</infon><infon key="type">ref</infon><infon key="volume">172</infon><infon key="year">2019</infon><offset>62678</offset><text>Characterization of estrogenic and androgenic activities for Bisphenol A-like Chemicals (BPs): in Vitro Estrogen and Androgen receptors Transcriptional activation, Gene Regulation, and binding profiles</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>62880</offset><text>Monniaux D, Cadoret V, Clement F, Dalbies-Tran R, Elis S, Fabre S, Maillard V, Monget P, Uzbekova S. Folliculogenesis. In: Encyclopedia of Endocrine Diseases (Second Edition). Edited by Huhtaniemi I, Martini L. Oxford: Academic Press; 2019: 377-398.</text></passage><passage><infon key="citation-alternatives">Campen KA, Lavallee M, Combelles C. The impact of bisphenol S on bovine granulosa and theca cells. Reprod Domest Anim. 2018;53(2):450-7.
</infon><infon key="fpage">450</infon><infon key="issue">2</infon><infon key="lpage">7</infon><infon key="name_0">surname:Campen;given-names:KA</infon><infon key="name_1">surname:Lavallee;given-names:M</infon><infon key="name_2">surname:Combelles;given-names:C</infon><infon key="pub-id_doi">10.1111/rda.13130</infon><infon key="pub-id_pmid">29330967</infon><infon key="section_type">REF</infon><infon key="source">Reprod Domest Anim</infon><infon key="type">ref</infon><infon key="volume">53</infon><infon key="year">2018</infon><offset>63133</offset><text>The impact of bisphenol S on bovine granulosa and theca cells</text></passage><passage><infon key="citation-alternatives">Berni M, Gigante P, Bussolati S, Grasselli F, Grolli S, Ramoni R, Basini G, Bisphenol S. A Bisphenol A alternative, impairs swine ovarian and adipose cell functions. Domest Anim Endocrinol. 2019;66:48-56.
</infon><infon key="fpage">48</infon><infon key="lpage">56</infon><infon key="name_0">surname:Berni;given-names:M</infon><infon key="name_1">surname:Gigante;given-names:P</infon><infon key="name_2">surname:Bussolati;given-names:S</infon><infon key="name_3">surname:Grasselli;given-names:F</infon><infon key="name_4">surname:Grolli;given-names:S</infon><infon key="name_5">surname:Ramoni;given-names:R</infon><infon key="name_6">surname:Basini;given-names:G</infon><infon key="name_7">surname:Bisphenol;given-names:S</infon><infon key="pub-id_doi">10.1016/j.domaniend.2018.08.001</infon><infon key="pub-id_pmid">30439591</infon><infon key="section_type">REF</infon><infon key="source">Domest Anim Endocrinol</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">2019</infon><offset>63195</offset><text>A Bisphenol A alternative, impairs swine ovarian and adipose cell functions</text></passage><passage><infon key="citation-alternatives">Bujnakova Mlynarcikova A, Scsukova S. Bisphenol analogs AF, S and F: effects on functional characteristics of porcine granulosa cells. Reprod Toxicol. 2021;103:18-27.
</infon><infon key="fpage">18</infon><infon key="lpage">27</infon><infon key="name_0">surname:Bujnakova Mlynarcikova;given-names:A</infon><infon key="name_1">surname:Scsukova;given-names:S</infon><infon key="pub-id_doi">10.1016/j.reprotox.2021.05.004</infon><infon key="pub-id_pmid">34019995</infon><infon key="section_type">REF</infon><infon key="source">Reprod Toxicol</infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="year">2021</infon><offset>63271</offset><text>Bisphenol analogs AF, S and F: effects on functional characteristics of porcine granulosa cells</text></passage><passage><infon key="citation-alternatives">Teteau O, Jaubert M, Desmarchais A, Papillier P, Binet A, Maillard V, Elis S. Bisphenol A and S impaired ovine granulosa cell steroidogenesis. Reproduction. 2020;159(5):571-83.
</infon><infon key="fpage">571</infon><infon key="issue">5</infon><infon key="lpage">83</infon><infon key="name_0">surname:Teteau;given-names:O</infon><infon key="name_1">surname:Jaubert;given-names:M</infon><infon key="name_2">surname:Desmarchais;given-names:A</infon><infon key="name_3">surname:Papillier;given-names:P</infon><infon key="name_4">surname:Binet;given-names:A</infon><infon key="name_5">surname:Maillard;given-names:V</infon><infon key="name_6">surname:Elis;given-names:S</infon><infon key="pub-id_doi">10.1530/REP-19-0575</infon><infon key="pub-id_pmid">32092037</infon><infon key="section_type">REF</infon><infon key="source">Reproduction</infon><infon key="type">ref</infon><infon key="volume">159</infon><infon key="year">2020</infon><offset>63367</offset><text>Bisphenol A and S impaired ovine granulosa cell steroidogenesis</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>63431</offset><text>Thoene M, Dzika E, Gonkowski S, Wojtkiewicz J. Bisphenol S in food causes hormonal and obesogenic effects comparable to or worse than bisphenol A: a literature review. Nutrients 2020, 12(2).</text></passage><passage><infon key="citation-alternatives">Fontana R, Torre S. The deep correlation between Energy Metabolism and Reproduction: a view on the effects of Nutrition for women Fertility. Nutrients. 2016;8(2):87.
</infon><infon key="fpage">87</infon><infon key="issue">2</infon><infon key="name_0">surname:Fontana;given-names:R</infon><infon key="name_1">surname:Torre;given-names:S</infon><infon key="pub-id_doi">10.3390/nu8020087</infon><infon key="pub-id_pmid">26875986</infon><infon key="section_type">REF</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2016</infon><offset>63622</offset><text>The deep correlation between Energy Metabolism and Reproduction: a view on the effects of Nutrition for women Fertility</text></passage><passage><infon key="citation-alternatives">Seli E, Babayev E, Collins SC, Nemeth G, Horvath TL. Minireview: metabolism of female reproduction: regulatory mechanisms and clinical implications. Mol Endocrinol. 2014;28(6):790-804.
</infon><infon key="fpage">790</infon><infon key="issue">6</infon><infon key="lpage">804</infon><infon key="name_0">surname:Seli;given-names:E</infon><infon key="name_1">surname:Babayev;given-names:E</infon><infon key="name_2">surname:Collins;given-names:SC</infon><infon key="name_3">surname:Nemeth;given-names:G</infon><infon key="name_4">surname:Horvath;given-names:TL</infon><infon key="pub-id_doi">10.1210/me.2013-1413</infon><infon key="pub-id_pmid">24678733</infon><infon key="section_type">REF</infon><infon key="source">Mol Endocrinol</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2014</infon><offset>63742</offset><text>Minireview: metabolism of female reproduction: regulatory mechanisms and clinical implications</text></passage><passage><infon key="citation-alternatives">Sharma Y, Galvao AM. Maternal obesity and ovarian failure: is leptin the culprit? Anim Reprod. 2022;19(4):e20230007.
</infon><infon key="fpage">e20230007</infon><infon key="issue">4</infon><infon key="name_0">surname:Sharma;given-names:Y</infon><infon key="name_1">surname:Galvao;given-names:AM</infon><infon key="pub-id_doi">10.1590/1984-3143-ar2023-0007</infon><infon key="pub-id_pmid">36855701</infon><infon key="section_type">REF</infon><infon key="source">Anim Reprod</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2022</infon><offset>63837</offset><text>Maternal obesity and ovarian failure: is leptin the culprit?</text></passage><passage><infon key="citation-alternatives">Talmor A, Dunphy B. Female obesity and infertility. Best Pract Res Clin Obstet Gynaecol. 2015;29(4):498-506.
</infon><infon key="fpage">498</infon><infon key="issue">4</infon><infon key="lpage">506</infon><infon key="name_0">surname:Talmor;given-names:A</infon><infon key="name_1">surname:Dunphy;given-names:B</infon><infon key="pub-id_doi">10.1016/j.bpobgyn.2014.10.014</infon><infon key="pub-id_pmid">25619586</infon><infon key="section_type">REF</infon><infon key="source">Best Pract Res Clin Obstet Gynaecol</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2015</infon><offset>63898</offset><text>Female obesity and infertility</text></passage><passage><infon key="citation-alternatives">Carwile JL, Michels KB. Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res. 2011;111(6):825-30.
</infon><infon key="fpage">825</infon><infon key="issue">6</infon><infon key="lpage">30</infon><infon key="name_0">surname:Carwile;given-names:JL</infon><infon key="name_1">surname:Michels;given-names:KB</infon><infon key="pub-id_doi">10.1016/j.envres.2011.05.014</infon><infon key="pub-id_pmid">21676388</infon><infon key="section_type">REF</infon><infon key="source">Environ Res</infon><infon key="type">ref</infon><infon key="volume">111</infon><infon key="year">2011</infon><offset>63929</offset><text>Urinary bisphenol A and obesity: NHANES 2003-2006</text></passage><passage><infon key="citation-alternatives">Wells EM, Jackson LW, Koontz MB. Association between bisphenol A and waist-to-height ratio among children: National Health and Nutrition Examination Survey, 2003-2010. Ann Epidemiol. 2014;24(2):165-7.
</infon><infon key="fpage">165</infon><infon key="issue">2</infon><infon key="lpage">7</infon><infon key="name_0">surname:Wells;given-names:EM</infon><infon key="name_1">surname:Jackson;given-names:LW</infon><infon key="name_2">surname:Koontz;given-names:MB</infon><infon key="pub-id_doi">10.1016/j.annepidem.2013.06.002</infon><infon key="pub-id_pmid">23830935</infon><infon key="section_type">REF</infon><infon key="source">Ann Epidemiol</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2014</infon><offset>63981</offset><text>Association between bisphenol A and waist-to-height ratio among children: National Health and Nutrition Examination Survey, 2003-2010</text></passage><passage><infon key="citation-alternatives">Martinez M, Blanco J, Rovira J, Kumar V, Domingo JL, Schuhmacher M, Bisphenol A. Analogues (BPS and BPF) present a greater obesogenic capacity in 3T3-L1 cell line. Food Chem Toxicol. 2020;140:111298.
</infon><infon key="fpage">111298</infon><infon key="name_0">surname:Martinez;given-names:M</infon><infon key="name_1">surname:Blanco;given-names:J</infon><infon key="name_2">surname:Rovira;given-names:J</infon><infon key="name_3">surname:Kumar;given-names:V</infon><infon key="name_4">surname:Domingo;given-names:JL</infon><infon key="name_5">surname:Schuhmacher;given-names:M</infon><infon key="name_6">surname:Bisphenol;given-names:A</infon><infon key="pub-id_doi">10.1016/j.fct.2020.111298</infon><infon key="pub-id_pmid">32220626</infon><infon key="section_type">REF</infon><infon key="source">Food Chem Toxicol</infon><infon key="type">ref</infon><infon key="volume">140</infon><infon key="year">2020</infon><offset>64117</offset><text>Analogues (BPS and BPF) present a greater obesogenic capacity in 3T3-L1 cell line</text></passage><passage><infon key="citation-alternatives">Tyner MDW, Maloney MO, Kelley BJB, Combelles CMH. Comparing the effects of bisphenol A, C, and F on bovine theca cells in vitro. Reprod Toxicol. 2022;111:27-33.
</infon><infon key="fpage">27</infon><infon key="lpage">33</infon><infon key="name_0">surname:Tyner;given-names:MDW</infon><infon key="name_1">surname:Maloney;given-names:MO</infon><infon key="name_2">surname:Kelley;given-names:BJB</infon><infon key="name_3">surname:Combelles;given-names:CMH</infon><infon key="pub-id_doi">10.1016/j.reprotox.2022.05.003</infon><infon key="pub-id_pmid">35577017</infon><infon key="section_type">REF</infon><infon key="source">Reprod Toxicol</infon><infon key="type">ref</infon><infon key="volume">111</infon><infon key="year">2022</infon><offset>64199</offset><text>Comparing the effects of bisphenol A, C, and F on bovine theca cells in vitro</text></passage><passage><infon key="citation-alternatives">Samardzija D, Pogrmic-Majkic K, Fa S, Stanic B, Jasnic J, Andric N. Bisphenol A decreases progesterone synthesis by disrupting cholesterol homeostasis in rat granulosa cells. Mol Cell Endocrinol. 2018;461:55-63.
</infon><infon key="fpage">55</infon><infon key="lpage">63</infon><infon key="name_0">surname:Samardzija;given-names:D</infon><infon key="name_1">surname:Pogrmic-Majkic;given-names:K</infon><infon key="name_2">surname:Fa;given-names:S</infon><infon key="name_3">surname:Stanic;given-names:B</infon><infon key="name_4">surname:Jasnic;given-names:J</infon><infon key="name_5">surname:Andric;given-names:N</infon><infon key="pub-id_doi">10.1016/j.mce.2017.08.013</infon><infon key="pub-id_pmid">28859904</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell Endocrinol</infon><infon key="type">ref</infon><infon key="volume">461</infon><infon key="year">2018</infon><offset>64277</offset><text>Bisphenol A decreases progesterone synthesis by disrupting cholesterol homeostasis in rat granulosa cells</text></passage><passage><infon key="citation-alternatives">Desmarchais A, Teteau O, Papillier P, Jaubert M, Druart X, Binet A, Maillard V, Elis S. Bisphenol S impaired in vitro ovine early developmental oocyte competence. Int J Mol Sci. 2020;21(4):1238.
</infon><infon key="fpage">1238</infon><infon key="issue">4</infon><infon key="name_0">surname:Desmarchais;given-names:A</infon><infon key="name_1">surname:Teteau;given-names:O</infon><infon key="name_2">surname:Papillier;given-names:P</infon><infon key="name_3">surname:Jaubert;given-names:M</infon><infon key="name_4">surname:Druart;given-names:X</infon><infon key="name_5">surname:Binet;given-names:A</infon><infon key="name_6">surname:Maillard;given-names:V</infon><infon key="name_7">surname:Elis;given-names:S</infon><infon key="pub-id_doi">10.3390/ijms21041238</infon><infon key="pub-id_pmid">32059612</infon><infon key="section_type">REF</infon><infon key="source">Int J Mol Sci</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2020</infon><offset>64383</offset><text>Bisphenol S impaired in vitro ovine early developmental oocyte competence</text></passage><passage><infon key="citation-alternatives">Teteau O, Liere P, Pianos A, Desmarchais A, Lasserre O, Papillier P, Vignault C, Lebachelier de la Riviere M-E, Maillard V, Binet A, et al. Bisphenol S alters the Steroidome in the Preovulatory follicle, Oviduct Fluid and plasma in Ewes with contrasted metabolic status. Front Endocrinol. 2022;13:892213.</infon><infon key="fpage">892213</infon><infon key="name_0">surname:Teteau;given-names:O</infon><infon key="name_1">surname:Liere;given-names:P</infon><infon key="name_2">surname:Pianos;given-names:A</infon><infon key="name_3">surname:Desmarchais;given-names:A</infon><infon key="name_4">surname:Lasserre;given-names:O</infon><infon key="name_5">surname:Papillier;given-names:P</infon><infon key="name_6">surname:Vignault;given-names:C</infon><infon key="name_7">surname:Lebachelier de la Riviere;given-names:M-E</infon><infon key="name_8">surname:Maillard;given-names:V</infon><infon key="name_9">surname:Binet;given-names:A</infon><infon key="pub-id_doi">10.3389/fendo.2022.892213</infon><infon key="section_type">REF</infon><infon key="source">Front Endocrinol</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2022</infon><offset>64457</offset><text>Bisphenol S alters the Steroidome in the Preovulatory follicle, Oviduct Fluid and plasma in Ewes with contrasted metabolic status</text></passage><passage><infon key="citation-alternatives">Desmarchais A, Teteau O, Kasal-Hoc N, Cognie J, Lasserre O, Papillier P, Lacroix M, Vignault C, Jarrier-Gaillard P, Maillard V, et al. Chronic low BPS exposure through diet impairs in vitro embryo production parameters according to metabolic status in the ewe. Ecotoxicol Environ Saf. 2022;229:113096.
</infon><infon key="fpage">113096</infon><infon key="name_0">surname:Desmarchais;given-names:A</infon><infon key="name_1">surname:Teteau;given-names:O</infon><infon key="name_2">surname:Kasal-Hoc;given-names:N</infon><infon key="name_3">surname:Cognie;given-names:J</infon><infon key="name_4">surname:Lasserre;given-names:O</infon><infon key="name_5">surname:Papillier;given-names:P</infon><infon key="name_6">surname:Lacroix;given-names:M</infon><infon key="name_7">surname:Vignault;given-names:C</infon><infon key="name_8">surname:Jarrier-Gaillard;given-names:P</infon><infon key="name_9">surname:Maillard;given-names:V</infon><infon key="pub-id_doi">10.1016/j.ecoenv.2021.113096</infon><infon key="pub-id_pmid">34952380</infon><infon key="section_type">REF</infon><infon key="source">Ecotoxicol Environ Saf</infon><infon key="type">ref</infon><infon key="volume">229</infon><infon key="year">2022</infon><offset>64587</offset><text>Chronic low BPS exposure through diet impairs in vitro embryo production parameters according to metabolic status in the ewe</text></passage><passage><infon key="citation-alternatives">Mahe C, de la Lebachelier ME, Lasserre O, Tsikis G, Tomas D, Labas V, Elis S, Saint-Dizier M. Oral exposure to bisphenol S is associated with alterations in the oviduct proteome of an ovine model, with aggravated effects in overfed females. BMC Genomics. 2024;25(1):589.
</infon><infon key="fpage">589</infon><infon key="issue">1</infon><infon key="name_0">surname:Mahe;given-names:C</infon><infon key="name_1">surname:de la Lebachelier;given-names:ME</infon><infon key="name_2">surname:Lasserre;given-names:O</infon><infon key="name_3">surname:Tsikis;given-names:G</infon><infon key="name_4">surname:Tomas;given-names:D</infon><infon key="name_5">surname:Labas;given-names:V</infon><infon key="name_6">surname:Elis;given-names:S</infon><infon key="name_7">surname:Saint-Dizier;given-names:M</infon><infon key="pub-id_doi">10.1186/s12864-024-10510-z</infon><infon key="pub-id_pmid">38867150</infon><infon key="section_type">REF</infon><infon key="source">BMC Genomics</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2024</infon><offset>64712</offset><text>Oral exposure to bisphenol S is associated with alterations in the oviduct proteome of an ovine model, with aggravated effects in overfed females</text></passage><passage><infon key="citation-alternatives">Huang R, Li J, Liao M, Ma L, Laurent I, Lin X, Zhang Y, Gao R, Ding Y, Xiao X. Combinational exposure to Bisphenol A and a high-fat diet causes trans-generational malfunction of the female reproductive system in mice. Mol Cell Endocrinol. 2022;541:111507.
</infon><infon key="fpage">111507</infon><infon key="name_0">surname:Huang;given-names:R</infon><infon key="name_1">surname:Li;given-names:J</infon><infon key="name_2">surname:Liao;given-names:M</infon><infon key="name_3">surname:Ma;given-names:L</infon><infon key="name_4">surname:Laurent;given-names:I</infon><infon key="name_5">surname:Lin;given-names:X</infon><infon key="name_6">surname:Zhang;given-names:Y</infon><infon key="name_7">surname:Gao;given-names:R</infon><infon key="name_8">surname:Ding;given-names:Y</infon><infon key="name_9">surname:Xiao;given-names:X</infon><infon key="pub-id_doi">10.1016/j.mce.2021.111507</infon><infon key="pub-id_pmid">34785282</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell Endocrinol</infon><infon key="type">ref</infon><infon key="volume">541</infon><infon key="year">2022</infon><offset>64858</offset><text>Combinational exposure to Bisphenol A and a high-fat diet causes trans-generational malfunction of the female reproductive system in mice</text></passage><passage><infon key="citation-alternatives">Tarapore P, Hennessy M, Song D, Ying J, Ouyang B, Govindarajah V, Leung YK, Ho SM. High butter-fat diet and bisphenol A additively impair male rat spermatogenesis. Reprod Toxicol. 2017;68:191-9.
</infon><infon key="fpage">191</infon><infon key="lpage">9</infon><infon key="name_0">surname:Tarapore;given-names:P</infon><infon key="name_1">surname:Hennessy;given-names:M</infon><infon key="name_2">surname:Song;given-names:D</infon><infon key="name_3">surname:Ying;given-names:J</infon><infon key="name_4">surname:Ouyang;given-names:B</infon><infon key="name_5">surname:Govindarajah;given-names:V</infon><infon key="name_6">surname:Leung;given-names:YK</infon><infon key="name_7">surname:Ho;given-names:SM</infon><infon key="pub-id_doi">10.1016/j.reprotox.2016.09.008</infon><infon key="pub-id_pmid">27658648</infon><infon key="section_type">REF</infon><infon key="source">Reprod Toxicol</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="year">2017</infon><offset>64996</offset><text>High butter-fat diet and bisphenol A additively impair male rat spermatogenesis</text></passage><passage><infon key="citation-alternatives">Kannan A, Davila J, Gao L, Rattan S, Flaws JA, Bagchi MK, Bagchi IC. Maternal high-fat diet during pregnancy with concurrent phthalate exposure leads to abnormal placentation. Sci Rep. 2021;11(1):16602.
</infon><infon key="fpage">16602</infon><infon key="issue">1</infon><infon key="name_0">surname:Kannan;given-names:A</infon><infon key="name_1">surname:Davila;given-names:J</infon><infon key="name_2">surname:Gao;given-names:L</infon><infon key="name_3">surname:Rattan;given-names:S</infon><infon key="name_4">surname:Flaws;given-names:JA</infon><infon key="name_5">surname:Bagchi;given-names:MK</infon><infon key="name_6">surname:Bagchi;given-names:IC</infon><infon key="pub-id_doi">10.1038/s41598-021-95898-4</infon><infon key="pub-id_pmid">34400704</infon><infon key="section_type">REF</infon><infon key="source">Sci Rep</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>65076</offset><text>Maternal high-fat diet during pregnancy with concurrent phthalate exposure leads to abnormal placentation</text></passage><passage><infon key="citation-alternatives">Zhang Y, Zhou L, Zhang Z, Xu Q, Han X, Zhao Y, Song X, Zhao T, Ye L. Effects of Di (2-ethylhexyl) phthalate and high-fat diet on lipid metabolism in rats by JAK2/STAT5. Environ Sci Pollut Res. 2020;27(4):3837-48.</infon><infon key="fpage">3837</infon><infon key="issue">4</infon><infon key="lpage">48</infon><infon key="name_0">surname:Zhang;given-names:Y</infon><infon key="name_1">surname:Zhou;given-names:L</infon><infon key="name_2">surname:Zhang;given-names:Z</infon><infon key="name_3">surname:Xu;given-names:Q</infon><infon key="name_4">surname:Han;given-names:X</infon><infon key="name_5">surname:Zhao;given-names:Y</infon><infon key="name_6">surname:Song;given-names:X</infon><infon key="name_7">surname:Zhao;given-names:T</infon><infon key="name_8">surname:Ye;given-names:L</infon><infon key="pub-id_doi">10.1007/s11356-019-06599-5</infon><infon key="section_type">REF</infon><infon key="source">Environ Sci Pollut Res</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2020</infon><offset>65182</offset><text>Effects of Di (2-ethylhexyl) phthalate and high-fat diet on lipid metabolism in rats by JAK2/STAT5</text></passage><passage><infon key="citation-alternatives">Marques ES, Agudelo J, Kaye EM, Modaresi SMS, Pfohl M, Becanova J, Wei W, Polunas M, Goedken M, Slitt AL. The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure. Toxicology. 2021;462:152921.
</infon><infon key="fpage">152921</infon><infon key="name_0">surname:Marques;given-names:ES</infon><infon key="name_1">surname:Agudelo;given-names:J</infon><infon key="name_2">surname:Kaye;given-names:EM</infon><infon key="name_3">surname:Modaresi;given-names:SMS</infon><infon key="name_4">surname:Pfohl;given-names:M</infon><infon key="name_5">surname:Becanova;given-names:J</infon><infon key="name_6">surname:Wei;given-names:W</infon><infon key="name_7">surname:Polunas;given-names:M</infon><infon key="name_8">surname:Goedken;given-names:M</infon><infon key="name_9">surname:Slitt;given-names:AL</infon><infon key="pub-id_doi">10.1016/j.tox.2021.152921</infon><infon key="pub-id_pmid">34464680</infon><infon key="section_type">REF</infon><infon key="source">Toxicology</infon><infon key="type">ref</infon><infon key="volume">462</infon><infon key="year">2021</infon><offset>65281</offset><text>The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure</text></passage><passage><infon key="citation-alternatives">Curtiss LK, Valenta DT, Hime NJ, Rye K-A. What is so special about apolipoprotein AI in Reverse Cholesterol Transport? Arterioscler Thromb Vasc Biol. 2006;26(1):12-9.
</infon><infon key="fpage">12</infon><infon key="issue">1</infon><infon key="lpage">9</infon><infon key="name_0">surname:Curtiss;given-names:LK</infon><infon key="name_1">surname:Valenta;given-names:DT</infon><infon key="name_2">surname:Hime;given-names:NJ</infon><infon key="name_3">surname:Rye;given-names:K-A</infon><infon key="pub-id_doi">10.1161/01.ATV.0000194291.94269.5a</infon><infon key="pub-id_pmid">16269660</infon><infon key="section_type">REF</infon><infon key="source">Arterioscler Thromb Vasc Biol</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2006</infon><offset>65400</offset><text>What is so special about apolipoprotein AI in Reverse Cholesterol Transport?</text></passage><passage><infon key="citation-alternatives">Roberts LM, Buford TW. Lipopolysaccharide binding protein is associated with CVD risk in older adults. Aging Clin Exp Res. 2021;33(6):1651-8.
</infon><infon key="fpage">1651</infon><infon key="issue">6</infon><infon key="lpage">8</infon><infon key="name_0">surname:Roberts;given-names:LM</infon><infon key="name_1">surname:Buford;given-names:TW</infon><infon key="pub-id_doi">10.1007/s40520-020-01684-z</infon><infon key="pub-id_pmid">32895891</infon><infon key="section_type">REF</infon><infon key="source">Aging Clin Exp Res</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2021</infon><offset>65477</offset><text>Lipopolysaccharide binding protein is associated with CVD risk in older adults</text></passage><passage><infon key="citation-alternatives">Meng L, Song Z, Liu A, Dahmen U, Yang X, Fang H. Effects of Lipopolysaccharide-binding protein (LBP) single nucleotide polymorphism (SNP) in infections, inflammatory diseases, metabolic disorders and cancers. Front Immunol. 2021;12:681810.
</infon><infon key="fpage">681810</infon><infon key="name_0">surname:Meng;given-names:L</infon><infon key="name_1">surname:Song;given-names:Z</infon><infon key="name_2">surname:Liu;given-names:A</infon><infon key="name_3">surname:Dahmen;given-names:U</infon><infon key="name_4">surname:Yang;given-names:X</infon><infon key="name_5">surname:Fang;given-names:H</infon><infon key="pub-id_doi">10.3389/fimmu.2021.681810</infon><infon key="pub-id_pmid">34295331</infon><infon key="section_type">REF</infon><infon key="source">Front Immunol</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2021</infon><offset>65556</offset><text>Effects of Lipopolysaccharide-binding protein (LBP) single nucleotide polymorphism (SNP) in infections, inflammatory diseases, metabolic disorders and cancers</text></passage><passage><infon key="citation-alternatives">Morris G, Puri BK, Bortolasci CC, Carvalho A, Berk M, Walder K, Moreira EG, Maes M. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders. Neurosci Biobehav Rev. 2021;125:244-63.
</infon><infon key="fpage">244</infon><infon key="lpage">63</infon><infon key="name_0">surname:Morris;given-names:G</infon><infon key="name_1">surname:Puri;given-names:BK</infon><infon key="name_2">surname:Bortolasci;given-names:CC</infon><infon key="name_3">surname:Carvalho;given-names:A</infon><infon key="name_4">surname:Berk;given-names:M</infon><infon key="name_5">surname:Walder;given-names:K</infon><infon key="name_6">surname:Moreira;given-names:EG</infon><infon key="name_7">surname:Maes;given-names:M</infon><infon key="pub-id_doi">10.1016/j.neubiorev.2021.02.037</infon><infon key="pub-id_pmid">33657433</infon><infon key="section_type">REF</infon><infon key="source">Neurosci Biobehav Rev</infon><infon key="type">ref</infon><infon key="volume">125</infon><infon key="year">2021</infon><offset>65715</offset><text>The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders</text></passage><passage><infon key="citation-alternatives">Aune SK, Helseth R, Kalstad AA, Laake K, Akra S, Arnesen H, Solheim S, Seljeflot I. Links between adipose tissue gene expression of gut leakage markers, circulating levels, Anthropometrics, and Diet in patients with coronary artery disease. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 2024;17:2177-90.
</infon><infon key="fpage">2177</infon><infon key="lpage">90</infon><infon key="name_0">surname:Aune;given-names:SK</infon><infon key="name_1">surname:Helseth;given-names:R</infon><infon key="name_2">surname:Kalstad;given-names:AA</infon><infon key="name_3">surname:Laake;given-names:K</infon><infon key="name_4">surname:Akra;given-names:S</infon><infon key="name_5">surname:Arnesen;given-names:H</infon><infon key="name_6">surname:Solheim;given-names:S</infon><infon key="name_7">surname:Seljeflot;given-names:I</infon><infon key="pub-id_doi">10.2147/DMSO.S438818</infon><infon key="pub-id_pmid">38827167</infon><infon key="section_type">REF</infon><infon key="source">Diabetes Metabolic Syndrome Obesity: Targets Therapy</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2024</infon><offset>65853</offset><text>Links between adipose tissue gene expression of gut leakage markers, circulating levels, Anthropometrics, and Diet in patients with coronary artery disease</text></passage><passage><infon key="citation-alternatives">Jarvis S, Gethings LA, Samanta L, Pedroni SMA, Withers DJ, Gray N, Plumb RS, Winston RML, Williamson C, Bevan CL. High fat diet causes distinct aberrations in the testicular proteome. Int J Obes (Lond). 2020;44(9):1958-69.
</infon><infon key="fpage">1958</infon><infon key="issue">9</infon><infon key="lpage">69</infon><infon key="name_0">surname:Jarvis;given-names:S</infon><infon key="name_1">surname:Gethings;given-names:LA</infon><infon key="name_2">surname:Samanta;given-names:L</infon><infon key="name_3">surname:Pedroni;given-names:SMA</infon><infon key="name_4">surname:Withers;given-names:DJ</infon><infon key="name_5">surname:Gray;given-names:N</infon><infon key="name_6">surname:Plumb;given-names:RS</infon><infon key="name_7">surname:Winston;given-names:RML</infon><infon key="name_8">surname:Williamson;given-names:C</infon><infon key="name_9">surname:Bevan;given-names:CL</infon><infon key="pub-id_doi">10.1038/s41366-020-0595-6</infon><infon key="pub-id_pmid">32678325</infon><infon key="section_type">REF</infon><infon key="source">Int J Obes (Lond)</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">2020</infon><offset>66009</offset><text>High fat diet causes distinct aberrations in the testicular proteome</text></passage><passage><infon key="citation-alternatives">Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, Dandona P. Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care. 2009;32(12):2281-7.
</infon><infon key="fpage">2281</infon><infon key="issue">12</infon><infon key="lpage">7</infon><infon key="name_0">surname:Ghanim;given-names:H</infon><infon key="name_1">surname:Abuaysheh;given-names:S</infon><infon key="name_2">surname:Sia;given-names:CL</infon><infon key="name_3">surname:Korzeniewski;given-names:K</infon><infon key="name_4">surname:Chaudhuri;given-names:A</infon><infon key="name_5">surname:Fernandez-Real;given-names:JM</infon><infon key="name_6">surname:Dandona;given-names:P</infon><infon key="pub-id_doi">10.2337/dc09-0979</infon><infon key="pub-id_pmid">19755625</infon><infon key="section_type">REF</infon><infon key="source">Diabetes Care</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2009</infon><offset>66078</offset><text>Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance</text></passage><passage><infon key="citation-alternatives">Meng Y, Yannan Z, Ren L, Qi S, Wei W, Lihong J. Adverse reproductive function induced by maternal BPA exposure is associated with abnormal autophagy and activating inflamation via mTOR and TLR4/NF-kappaB signaling pathways in female offspring rats. Reprod Toxicol. 2020;96:185-94.
</infon><infon key="fpage">185</infon><infon key="lpage">94</infon><infon key="name_0">surname:Meng;given-names:Y</infon><infon key="name_1">surname:Yannan;given-names:Z</infon><infon key="name_2">surname:Ren;given-names:L</infon><infon key="name_3">surname:Qi;given-names:S</infon><infon key="name_4">surname:Wei;given-names:W</infon><infon key="name_5">surname:Lihong;given-names:J</infon><infon key="pub-id_doi">10.1016/j.reprotox.2020.07.001</infon><infon key="pub-id_pmid">32634549</infon><infon key="section_type">REF</infon><infon key="source">Reprod Toxicol</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">2020</infon><offset>66302</offset><text>Adverse reproductive function induced by maternal BPA exposure is associated with abnormal autophagy and activating inflamation via mTOR and TLR4/NF-kappaB signaling pathways in female offspring rats</text></passage><passage><infon key="citation-alternatives">Morishima A, Ohkubo N, Maeda N, Miki T, Mitsuda N. NFkappaB regulates plasma apolipoprotein A-I and High Density Lipoprotein Cholesterol through inhibition of peroxisome proliferator-activated receptor alpha*. J Biol Chem. 2003;278(40):38188-93.
</infon><infon key="fpage">38188</infon><infon key="issue">40</infon><infon key="lpage">93</infon><infon key="name_0">surname:Morishima;given-names:A</infon><infon key="name_1">surname:Ohkubo;given-names:N</infon><infon key="name_2">surname:Maeda;given-names:N</infon><infon key="name_3">surname:Miki;given-names:T</infon><infon key="name_4">surname:Mitsuda;given-names:N</infon><infon key="pub-id_doi">10.1074/jbc.M306336200</infon><infon key="pub-id_pmid">12882972</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">278</infon><infon key="year">2003</infon><offset>66502</offset><text>NFkappaB regulates plasma apolipoprotein A-I and High Density Lipoprotein Cholesterol through inhibition of peroxisome proliferator-activated receptor alpha*</text></passage><passage><infon key="citation-alternatives">Pal S, Sahu A, Verma R, Haldar C. BPS-induced ovarian dysfunction: protective actions of melatonin via modulation of SIRT-1/Nrf2/NFkB and IR/PI3K/pAkt/GLUT-4 expressions in adult golden hamster. J Pineal Res. 2023;75(1):e12869.
</infon><infon key="fpage">e12869</infon><infon key="issue">1</infon><infon key="name_0">surname:Pal;given-names:S</infon><infon key="name_1">surname:Sahu;given-names:A</infon><infon key="name_2">surname:Verma;given-names:R</infon><infon key="name_3">surname:Haldar;given-names:C</infon><infon key="pub-id_doi">10.1111/jpi.12869</infon><infon key="pub-id_pmid">37002642</infon><infon key="section_type">REF</infon><infon key="source">J Pineal Res</infon><infon key="type">ref</infon><infon key="volume">75</infon><infon key="year">2023</infon><offset>66660</offset><text>BPS-induced ovarian dysfunction: protective actions of melatonin via modulation of SIRT-1/Nrf2/NFkB and IR/PI3K/pAkt/GLUT-4 expressions in adult golden hamster</text></passage><passage><infon key="citation-alternatives">Trusca VG, Dumitrescu M, Fenyo IM, Tudorache IF, Simionescu M, Gafencu AV. The mechanism of Bisphenol A Atherogenicity involves apolipoprotein A-I downregulation through NF-kappaB activation. Int J Mol Sci. 2019;20(24):6281.
</infon><infon key="fpage">6281</infon><infon key="issue">24</infon><infon key="name_0">surname:Trusca;given-names:VG</infon><infon key="name_1">surname:Dumitrescu;given-names:M</infon><infon key="name_2">surname:Fenyo;given-names:IM</infon><infon key="name_3">surname:Tudorache;given-names:IF</infon><infon key="name_4">surname:Simionescu;given-names:M</infon><infon key="name_5">surname:Gafencu;given-names:AV</infon><infon key="pub-id_doi">10.3390/ijms20246281</infon><infon key="pub-id_pmid">31842455</infon><infon key="section_type">REF</infon><infon key="source">Int J Mol Sci</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2019</infon><offset>66821</offset><text>The mechanism of Bisphenol A Atherogenicity involves apolipoprotein A-I downregulation through NF-kappaB activation</text></passage><passage><infon key="citation-alternatives">Tachmazidou I, Suveges D, Min JL, Ritchie GRS, Steinberg J, Walter K, Iotchkova V, Schwartzentruber J, Huang J, Memari Y, et al. Whole-genome sequencing coupled to Imputation Discovers Genetic Signals for anthropometric traits. Am J Hum Genet. 2017;100(6):865-84.
</infon><infon key="fpage">865</infon><infon key="issue">6</infon><infon key="lpage">84</infon><infon key="name_0">surname:Tachmazidou;given-names:I</infon><infon key="name_1">surname:Suveges;given-names:D</infon><infon key="name_2">surname:Min;given-names:JL</infon><infon key="name_3">surname:Ritchie;given-names:GRS</infon><infon key="name_4">surname:Steinberg;given-names:J</infon><infon key="name_5">surname:Walter;given-names:K</infon><infon key="name_6">surname:Iotchkova;given-names:V</infon><infon key="name_7">surname:Schwartzentruber;given-names:J</infon><infon key="name_8">surname:Huang;given-names:J</infon><infon key="name_9">surname:Memari;given-names:Y</infon><infon key="pub-id_doi">10.1016/j.ajhg.2017.04.014</infon><infon key="pub-id_pmid">28552196</infon><infon key="section_type">REF</infon><infon key="source">Am J Hum Genet</infon><infon key="type">ref</infon><infon key="volume">100</infon><infon key="year">2017</infon><offset>66937</offset><text>Whole-genome sequencing coupled to Imputation Discovers Genetic Signals for anthropometric traits</text></passage><passage><infon key="citation-alternatives">Warner ET, Jiang L, Adjei DN, Turman C, Gordon W, Wang L, Tamimi R, Kraft P, Lindstrom S. A Genome-Wide Association Study of Childhood Body Fatness. Obes (Silver Spring). 2021;29(2):446-53.</infon><infon key="fpage">446</infon><infon key="issue">2</infon><infon key="lpage">53</infon><infon key="name_0">surname:Warner;given-names:ET</infon><infon key="name_1">surname:Jiang;given-names:L</infon><infon key="name_2">surname:Adjei;given-names:DN</infon><infon key="name_3">surname:Turman;given-names:C</infon><infon key="name_4">surname:Gordon;given-names:W</infon><infon key="name_5">surname:Wang;given-names:L</infon><infon key="name_6">surname:Tamimi;given-names:R</infon><infon key="name_7">surname:Kraft;given-names:P</infon><infon key="name_8">surname:Lindstrom;given-names:S</infon><infon key="pub-id_doi">10.1002/oby.23070</infon><infon key="section_type">REF</infon><infon key="source">Obes (Silver Spring)</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2021</infon><offset>67035</offset><text>A Genome-Wide Association Study of Childhood Body Fatness</text></passage><passage><infon key="citation-alternatives">Tansey TR, Shechter I. Structure and regulation of mammalian squalene synthase. Biochim Biophys Acta. 2000;1529(1-3):49-62.
</infon><infon key="fpage">49</infon><infon key="issue">1-3</infon><infon key="lpage">62</infon><infon key="name_0">surname:Tansey;given-names:TR</infon><infon key="name_1">surname:Shechter;given-names:I</infon><infon key="pub-id_doi">10.1016/S1388-1981(00)00137-2</infon><infon key="pub-id_pmid">11111077</infon><infon key="section_type">REF</infon><infon key="source">Biochim Biophys Acta</infon><infon key="type">ref</infon><infon key="volume">1529</infon><infon key="year">2000</infon><offset>67093</offset><text>Structure and regulation of mammalian squalene synthase</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>67149</offset><text>Alharbi HF, Algonaiman R, Alduwayghiri R, Aljutaily T, Algheshairy RM, Almutairi AS, Alharbi RM, Alfurayh LA, Alshahwan AA, Alsadun AF et al. Exposure to Bisphenol A substitutes, Bisphenol S and Bisphenol F, and its Association with developing obesity and diabetes Mellitus: a narrative review. Int J Environ Res Public Health 2022, 19(23).</text></passage><passage><infon key="citation-alternatives">Boucher JG, Ahmed S, Atlas E. Bisphenol S induces adipogenesis in primary human preadipocytes from female donors. Endocrinology. 2016;157(4):1397-407.
</infon><infon key="fpage">1397</infon><infon key="issue">4</infon><infon key="lpage">407</infon><infon key="name_0">surname:Boucher;given-names:JG</infon><infon key="name_1">surname:Ahmed;given-names:S</infon><infon key="name_2">surname:Atlas;given-names:E</infon><infon key="pub-id_doi">10.1210/en.2015-1872</infon><infon key="pub-id_pmid">27003841</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">157</infon><infon key="year">2016</infon><offset>67490</offset><text>Bisphenol S induces adipogenesis in primary human preadipocytes from female donors</text></passage><passage><infon key="citation-alternatives">Song Ba Y, Wang Ma F, Wei Ma Y, Chen Ba D, Deng Ba G. ATP5A1 participates in Transcriptional and Posttranscriptional Regulation of Cancer-Associated genes by modulating their expression and alternative splicing profiles in HeLa cells. Technol Cancer Res Treat. 2021;20:15330338211039126.
</infon><infon key="fpage">15330338211039126</infon><infon key="name_0">surname:Song Ba;given-names:Y</infon><infon key="name_1">surname:Wang Ma;given-names:F</infon><infon key="name_2">surname:Wei Ma;given-names:Y</infon><infon key="name_3">surname:Chen Ba;given-names:D</infon><infon key="name_4">surname:Deng Ba;given-names:G</infon><infon key="pub-id_doi">10.1177/15330338211039126</infon><infon key="pub-id_pmid">34520292</infon><infon key="section_type">REF</infon><infon key="source">Technol Cancer Res Treat</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2021</infon><offset>67573</offset><text>ATP5A1 participates in Transcriptional and Posttranscriptional Regulation of Cancer-Associated genes by modulating their expression and alternative splicing profiles in HeLa cells</text></passage><passage><infon key="citation-alternatives">Maniam S, Coutts AS, Stratford MR, McGouran J, Kessler B, La Thangue NB. Cofactor strap regulates oxidative phosphorylation and mitochondrial p53 activity through ATP synthase. Cell Death Differ. 2015;22(1):156-63.
</infon><infon key="fpage">156</infon><infon key="issue">1</infon><infon key="lpage">63</infon><infon key="name_0">surname:Maniam;given-names:S</infon><infon key="name_1">surname:Coutts;given-names:AS</infon><infon key="name_2">surname:Stratford;given-names:MR</infon><infon key="name_3">surname:McGouran;given-names:J</infon><infon key="name_4">surname:Kessler;given-names:B</infon><infon key="name_5">surname:La Thangue;given-names:NB</infon><infon key="pub-id_doi">10.1038/cdd.2014.135</infon><infon key="pub-id_pmid">25168243</infon><infon key="section_type">REF</infon><infon key="source">Cell Death Differ</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2015</infon><offset>67753</offset><text>Cofactor strap regulates oxidative phosphorylation and mitochondrial p53 activity through ATP synthase</text></passage><passage><infon key="citation-alternatives">Hou S, Hao Q, Zhu Z, Xu D, Liu W, Lyu L, Li P. Unraveling proteome changes and potential regulatory proteins of bovine follicular granulosa cells by mass spectrometry and multi-omics analysis. Proteome Sci. 2019;17:4.
</infon><infon key="fpage">4</infon><infon key="name_0">surname:Hou;given-names:S</infon><infon key="name_1">surname:Hao;given-names:Q</infon><infon key="name_2">surname:Zhu;given-names:Z</infon><infon key="name_3">surname:Xu;given-names:D</infon><infon key="name_4">surname:Liu;given-names:W</infon><infon key="name_5">surname:Lyu;given-names:L</infon><infon key="name_6">surname:Li;given-names:P</infon><infon key="pub-id_doi">10.1186/s12953-019-0152-1</infon><infon key="pub-id_pmid">31673248</infon><infon key="section_type">REF</infon><infon key="source">Proteome Sci</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2019</infon><offset>67856</offset><text>Unraveling proteome changes and potential regulatory proteins of bovine follicular granulosa cells by mass spectrometry and multi-omics analysis</text></passage><passage><infon key="citation-alternatives">Elis S, Desmarchais A, Maillard V, Uzbekova S, Monget P, Dupont J. Cell proliferation and progesterone synthesis depend on lipid metabolism in bovine granulosa cells. Theriogenology. 2015;83(5):840-53.
</infon><infon key="fpage">840</infon><infon key="issue">5</infon><infon key="lpage">53</infon><infon key="name_0">surname:Elis;given-names:S</infon><infon key="name_1">surname:Desmarchais;given-names:A</infon><infon key="name_2">surname:Maillard;given-names:V</infon><infon key="name_3">surname:Uzbekova;given-names:S</infon><infon key="name_4">surname:Monget;given-names:P</infon><infon key="name_5">surname:Dupont;given-names:J</infon><infon key="pub-id_doi">10.1016/j.theriogenology.2014.11.019</infon><infon key="pub-id_pmid">25583222</infon><infon key="section_type">REF</infon><infon key="source">Theriogenology</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">2015</infon><offset>68001</offset><text>Cell proliferation and progesterone synthesis depend on lipid metabolism in bovine granulosa cells</text></passage><passage><infon key="citation-alternatives">McEvoy TG, Coull GD, Broadbent PJ, Hutchinson JS, Speake BK. Fatty acid composition of lipids in immature cattle, pig and sheep oocytes with intact zona pellucida. J Reprod Fertil. 2000;118(1):163-70.
</infon><infon key="fpage">163</infon><infon key="issue">1</infon><infon key="lpage">70</infon><infon key="name_0">surname:McEvoy;given-names:TG</infon><infon key="name_1">surname:Coull;given-names:GD</infon><infon key="name_2">surname:Broadbent;given-names:PJ</infon><infon key="name_3">surname:Hutchinson;given-names:JS</infon><infon key="name_4">surname:Speake;given-names:BK</infon><infon key="pub-id_doi">10.1530/reprod/118.1.163</infon><infon key="pub-id_pmid">10793638</infon><infon key="section_type">REF</infon><infon key="source">J Reprod Fertil</infon><infon key="type">ref</infon><infon key="volume">118</infon><infon key="year">2000</infon><offset>68100</offset><text>Fatty acid composition of lipids in immature cattle, pig and sheep oocytes with intact zona pellucida</text></passage><passage><infon key="citation-alternatives">Xue Y, Guo C, Hu F, Zhu W, Mao S. Undernutrition-induced lipid metabolism disorder triggers oxidative stress in maternal and fetal livers using a model of pregnant sheep. FASEB J. 2020;34(5):6508-20.
</infon><infon key="fpage">6508</infon><infon key="issue">5</infon><infon key="lpage">20</infon><infon key="name_0">surname:Xue;given-names:Y</infon><infon key="name_1">surname:Guo;given-names:C</infon><infon key="name_2">surname:Hu;given-names:F</infon><infon key="name_3">surname:Zhu;given-names:W</infon><infon key="name_4">surname:Mao;given-names:S</infon><infon key="pub-id_doi">10.1096/fj.201902537R</infon><infon key="pub-id_pmid">32232897</infon><infon key="section_type">REF</infon><infon key="source">FASEB J</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2020</infon><offset>68202</offset><text>Undernutrition-induced lipid metabolism disorder triggers oxidative stress in maternal and fetal livers using a model of pregnant sheep</text></passage><passage><infon key="citation-alternatives">Mandrah K, Jain V, Ansari JA, Roy SK. Metabolomic perturbation precedes glycolytic dysfunction and procreates hyperglycemia in a rat model due to bisphenol S exposure. Environ Toxicol Pharmacol. 2020;77:103372.
</infon><infon key="fpage">103372</infon><infon key="name_0">surname:Mandrah;given-names:K</infon><infon key="name_1">surname:Jain;given-names:V</infon><infon key="name_2">surname:Ansari;given-names:JA</infon><infon key="name_3">surname:Roy;given-names:SK</infon><infon key="pub-id_doi">10.1016/j.etap.2020.103372</infon><infon key="pub-id_pmid">32203925</infon><infon key="section_type">REF</infon><infon key="source">Environ Toxicol Pharmacol</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="year">2020</infon><offset>68338</offset><text>Metabolomic perturbation precedes glycolytic dysfunction and procreates hyperglycemia in a rat model due to bisphenol S exposure</text></passage><passage><infon key="citation-alternatives">Paigen K. Mammalian beta-glucuronidase: genetics, molecular biology, and cell biology. Prog Nucleic Acid Res Mol Biol. 1989;37:155-205.
</infon><infon key="fpage">155</infon><infon key="lpage">205</infon><infon key="name_0">surname:Paigen;given-names:K</infon><infon key="pub-id_doi">10.1016/S0079-6603(08)60698-4</infon><infon key="pub-id_pmid">2672109</infon><infon key="section_type">REF</infon><infon key="source">Prog Nucleic Acid Res Mol Biol</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">1989</infon><offset>68467</offset><text>Mammalian beta-glucuronidase: genetics, molecular biology, and cell biology</text></passage><passage><infon key="citation-alternatives">Edlow AG, Chen M, Smith NA, Lu C, McElrath TF. Fetal bisphenol A exposure: concentration of conjugated and unconjugated bisphenol A in amniotic fluid in the second and third trimesters. Reprod Toxicol. 2012;34(1):1-7.
</infon><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="lpage">7</infon><infon key="name_0">surname:Edlow;given-names:AG</infon><infon key="name_1">surname:Chen;given-names:M</infon><infon key="name_2">surname:Smith;given-names:NA</infon><infon key="name_3">surname:Lu;given-names:C</infon><infon key="name_4">surname:McElrath;given-names:TF</infon><infon key="pub-id_doi">10.1016/j.reprotox.2012.03.009</infon><infon key="pub-id_pmid">22516041</infon><infon key="section_type">REF</infon><infon key="source">Reprod Toxicol</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2012</infon><offset>68543</offset><text>Fetal bisphenol A exposure: concentration of conjugated and unconjugated bisphenol A in amniotic fluid in the second and third trimesters</text></passage><passage><infon key="citation-alternatives">Skledar DG, Schmidt J, Fic A, Klopcic I, Trontelj J, Dolenc MS, Finel M, Masic LP. Influence of metabolism on endocrine activities of bisphenol S. Chemosphere. 2016;157:152-9.
</infon><infon key="fpage">152</infon><infon key="lpage">9</infon><infon key="name_0">surname:Skledar;given-names:DG</infon><infon key="name_1">surname:Schmidt;given-names:J</infon><infon key="name_2">surname:Fic;given-names:A</infon><infon key="name_3">surname:Klopcic;given-names:I</infon><infon key="name_4">surname:Trontelj;given-names:J</infon><infon key="name_5">surname:Dolenc;given-names:MS</infon><infon key="name_6">surname:Finel;given-names:M</infon><infon key="name_7">surname:Masic;given-names:LP</infon><infon key="pub-id_doi">10.1016/j.chemosphere.2016.05.027</infon><infon key="pub-id_pmid">27213244</infon><infon key="section_type">REF</infon><infon key="source">Chemosphere</infon><infon key="type">ref</infon><infon key="volume">157</infon><infon key="year">2016</infon><offset>68681</offset><text>Influence of metabolism on endocrine activities of bisphenol S</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>68744</offset><text>Pellerin E, Pellerin FA, Chabaud S, Pouliot F, Pelletier M, Bolduc S. Glucuronidated metabolites of Bisphenols A and S alter the properties of normal urothelial and bladder Cancer cells. Int J Mol Sci 2022, 23(21).</text></passage><passage><infon key="citation-alternatives">Peillex C, Kerever A, Lachhab A, Pelletier M. Bisphenol A, bisphenol S and their glucuronidated metabolites modulate glycolysis and functional responses of human neutrophils. Environ Res. 2021;196:110336.
</infon><infon key="fpage">110336</infon><infon key="name_0">surname:Peillex;given-names:C</infon><infon key="name_1">surname:Kerever;given-names:A</infon><infon key="name_2">surname:Lachhab;given-names:A</infon><infon key="name_3">surname:Pelletier;given-names:M</infon><infon key="pub-id_doi">10.1016/j.envres.2020.110336</infon><infon key="pub-id_pmid">33091430</infon><infon key="section_type">REF</infon><infon key="source">Environ Res</infon><infon key="type">ref</infon><infon key="volume">196</infon><infon key="year">2021</infon><offset>68960</offset><text>Bisphenol A, bisphenol S and their glucuronidated metabolites modulate glycolysis and functional responses of human neutrophils</text></passage><passage><infon key="citation-alternatives">Maruti SS, Li L, Chang JL, Prunty J, Schwarz Y, Li SS, King IB, Potter JD, Lampe JW. Dietary and demographic correlates of serum beta-glucuronidase activity. Nutr Cancer. 2010;62(2):208-19.
</infon><infon key="fpage">208</infon><infon key="issue">2</infon><infon key="lpage">19</infon><infon key="name_0">surname:Maruti;given-names:SS</infon><infon key="name_1">surname:Li;given-names:L</infon><infon key="name_2">surname:Chang;given-names:JL</infon><infon key="name_3">surname:Prunty;given-names:J</infon><infon key="name_4">surname:Schwarz;given-names:Y</infon><infon key="name_5">surname:Li;given-names:SS</infon><infon key="name_6">surname:King;given-names:IB</infon><infon key="name_7">surname:Potter;given-names:JD</infon><infon key="name_8">surname:Lampe;given-names:JW</infon><infon key="pub-id_doi">10.1080/01635580903305375</infon><infon key="pub-id_pmid">20099195</infon><infon key="section_type">REF</infon><infon key="source">Nutr Cancer</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="year">2010</infon><offset>69088</offset><text>Dietary and demographic correlates of serum beta-glucuronidase activity</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>69160</offset><text>Gratz M, Kunert-Keil C, John U, Cascorbi I, Kroemer HK. Identification and functional analysis of genetic variants of the human beta-glucuronidase in a German population sample. Pharmacogen Genomics 2005, 15(12).</text></passage><passage><infon key="citation-alternatives">Lombardo A, Bairati C, Goi G, Roggi C, Maccarini L, Bollini D, Burlina A. Plasma lysosomal glycohydrolases in a general population. Clin Chim Acta. 1996;247(1-2):39-49.
</infon><infon key="fpage">39</infon><infon key="issue">1-2</infon><infon key="lpage">49</infon><infon key="name_0">surname:Lombardo;given-names:A</infon><infon key="name_1">surname:Bairati;given-names:C</infon><infon key="name_2">surname:Goi;given-names:G</infon><infon key="name_3">surname:Roggi;given-names:C</infon><infon key="name_4">surname:Maccarini;given-names:L</infon><infon key="name_5">surname:Bollini;given-names:D</infon><infon key="name_6">surname:Burlina;given-names:A</infon><infon key="pub-id_doi">10.1016/0009-8981(95)06218-1</infon><infon key="pub-id_pmid">8920225</infon><infon key="section_type">REF</infon><infon key="source">Clin Chim Acta</infon><infon key="type">ref</infon><infon key="volume">247</infon><infon key="year">1996</infon><offset>69373</offset><text>Plasma lysosomal glycohydrolases in a general population</text></passage><passage><infon key="citation-alternatives">Funk JL, Wertheim BC, Frye JB, Blew RM, Nicholas JS, Chen Z, Bea JW. Association of ss-glucuronidase activity with menopausal status, ethnicity, adiposity, and inflammation in women. Menopause. 2023;30(2):186-92.
</infon><infon key="fpage">186</infon><infon key="issue">2</infon><infon key="lpage">92</infon><infon key="name_0">surname:Funk;given-names:JL</infon><infon key="name_1">surname:Wertheim;given-names:BC</infon><infon key="name_2">surname:Frye;given-names:JB</infon><infon key="name_3">surname:Blew;given-names:RM</infon><infon key="name_4">surname:Nicholas;given-names:JS</infon><infon key="name_5">surname:Chen;given-names:Z</infon><infon key="name_6">surname:Bea;given-names:JW</infon><infon key="pub-id_doi">10.1097/GME.0000000000002106</infon><infon key="pub-id_pmid">36696643</infon><infon key="section_type">REF</infon><infon key="source">Menopause</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2023</infon><offset>69430</offset><text>Association of ss-glucuronidase activity with menopausal status, ethnicity, adiposity, and inflammation in women</text></passage><passage><infon key="citation-alternatives">Russel AJF, Doney JM, Gunn RG. Subjective assessment of body fat in live sheep. J Agricultural Sci. 1969;72(3):451-4.</infon><infon key="fpage">451</infon><infon key="issue">3</infon><infon key="lpage">4</infon><infon key="name_0">surname:Russel;given-names:AJF</infon><infon key="name_1">surname:Doney;given-names:JM</infon><infon key="name_2">surname:Gunn;given-names:RG</infon><infon key="pub-id_doi">10.1017/S0021859600024874</infon><infon key="section_type">REF</infon><infon key="source">J Agricultural Sci</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">1969</infon><offset>69543</offset><text>Subjective assessment of body fat in live sheep</text></passage><passage><infon key="citation-alternatives">Agabriel J. INRA Alimentation Des Bovines, Ovins et Caprins: Besoins Des Animaux - Valeurs Des Aliments. Tables INRA 2007, mise a jour 2010. Versailles, France: editions Quae; 2013.</infon><infon key="name_0">surname:Agabriel;given-names:J</infon><infon key="section_type">REF</infon><infon key="source">INRA Alimentation Des Bovines, Ovins et Caprins: Besoins Des Animaux - Valeurs Des Aliments. Tables INRA 2007, mise a jour 2010</infon><infon key="type">ref</infon><infon key="year">2013</infon><offset>69591</offset></passage><passage><infon key="citation-alternatives">Labas V, Grasseau I, Cahier K, Gargaros A, Harichaux G, Teixeira-Gomes A-P, Alves S, Bourin M, Gerard N, Blesbois E. Qualitative and quantitative peptidomic and proteomic approaches to phenotyping chicken semen. J Proteom. 2015;112:313-35.</infon><infon key="fpage">313</infon><infon key="lpage">35</infon><infon key="name_0">surname:Labas;given-names:V</infon><infon key="name_1">surname:Grasseau;given-names:I</infon><infon key="name_2">surname:Cahier;given-names:K</infon><infon key="name_3">surname:Gargaros;given-names:A</infon><infon key="name_4">surname:Harichaux;given-names:G</infon><infon key="name_5">surname:Teixeira-Gomes;given-names:A-P</infon><infon key="name_6">surname:Alves;given-names:S</infon><infon key="name_7">surname:Bourin;given-names:M</infon><infon key="name_8">surname:Gerard;given-names:N</infon><infon key="name_9">surname:Blesbois;given-names:E</infon><infon key="pub-id_doi">10.1016/j.jprot.2014.07.024</infon><infon key="section_type">REF</infon><infon key="source">J Proteom</infon><infon key="type">ref</infon><infon key="volume">112</infon><infon key="year">2015</infon><offset>69592</offset><text>Qualitative and quantitative peptidomic and proteomic approaches to phenotyping chicken semen</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>69686</offset><text>Harris L, Fondrie WE, Oh S, Noble WS. Evaluating proteomics imputation methods with improved criteria. bioRxiv 2023:2023.2004.2007.535980.</text></passage><passage><infon key="citation-alternatives">Bardou P, Mariette J, Escudie F, Djemiel C, Klopp C. Jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014;15(1):293.
</infon><infon key="fpage">293</infon><infon key="issue">1</infon><infon key="name_0">surname:Bardou;given-names:P</infon><infon key="name_1">surname:Mariette;given-names:J</infon><infon key="name_2">surname:Escudie;given-names:F</infon><infon key="name_3">surname:Djemiel;given-names:C</infon><infon key="name_4">surname:Klopp;given-names:C</infon><infon key="pub-id_doi">10.1186/1471-2105-15-293</infon><infon key="pub-id_pmid">25176396</infon><infon key="section_type">REF</infon><infon key="source">BMC Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2014</infon><offset>69825</offset><text>Jvenn: an interactive Venn diagram viewer</text></passage><passage><infon key="citation-alternatives">Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
</infon><infon key="fpage">1523</infon><infon key="issue">1</infon><infon key="name_0">surname:Zhou;given-names:Y</infon><infon key="name_1">surname:Zhou;given-names:B</infon><infon key="name_2">surname:Pache;given-names:L</infon><infon key="name_3">surname:Chang;given-names:M</infon><infon key="name_4">surname:Khodabakhshi;given-names:AH</infon><infon key="name_5">surname:Tanaseichuk;given-names:O</infon><infon key="name_6">surname:Benner;given-names:C</infon><infon key="name_7">surname:Chanda;given-names:SK</infon><infon key="pub-id_doi">10.1038/s41467-019-09234-6</infon><infon key="pub-id_pmid">30944313</infon><infon key="section_type">REF</infon><infon key="source">Nat Commun</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2019</infon><offset>69867</offset><text>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</text></passage><passage><infon key="citation-alternatives">Liebermeister W, Noor E, Flamholz A, Davidi D, Bernhardt J, Milo R. Visual account of protein investment in cellular functions. Proc Natl Acad Sci U S A. 2014;111(23):8488-93.
</infon><infon key="fpage">8488</infon><infon key="issue">23</infon><infon key="lpage">93</infon><infon key="name_0">surname:Liebermeister;given-names:W</infon><infon key="name_1">surname:Noor;given-names:E</infon><infon key="name_2">surname:Flamholz;given-names:A</infon><infon key="name_3">surname:Davidi;given-names:D</infon><infon key="name_4">surname:Bernhardt;given-names:J</infon><infon key="name_5">surname:Milo;given-names:R</infon><infon key="pub-id_doi">10.1073/pnas.1314810111</infon><infon key="pub-id_pmid">24889604</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">111</infon><infon key="year">2014</infon><offset>69959</offset><text>Visual account of protein investment in cellular functions</text></passage></document>
</collection>